data_2ndl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ndl _Structure_validation_residue.Date_analyzed 2016-12-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.43 0.461 . . . . 64.010000000000005 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -164.82 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.681 2.254 . . . . 74.519999999999996 112.379 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.29 149.79 24.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 71.519999999999996 110.896 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -140.99 139.84 20.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.628 0.728 . . . . 73.239999999999995 110.861 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 80.08 0.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.686 2.258 . . . . 74.540000000000006 112.392 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.3 mtm -151.14 178.69 8.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.891 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.79 -172.02 54.16 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 63.119999999999997 112.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.42 18.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.74 2.293 . . . . 74.349999999999994 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -91.43 -43.85 9.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 74.150000000000006 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.79 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.773 -0.727 . . . . 72.439999999999998 112.509 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 81.37 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.653 2.235 . . . . 74.109999999999999 112.391 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 144.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.120000000000005 110.86 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.13 150.5 26.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.209999999999994 110.921 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.71 158.65 35.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.140000000000001 111.134 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -28.99 24.16 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.681 2.254 . . . . 74.329999999999998 112.339 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.929 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.406 0.448 . . . . 54.200000000000003 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.709 2.272 . . . . 75.219999999999999 112.324 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.16 149.93 24.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 73.530000000000001 110.849 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -141.14 139.74 19.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 75.109999999999999 110.837 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 80.22 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.725 2.283 . . . . 72.340000000000003 112.385 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 mtp -151.39 178.73 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 73.140000000000001 110.878 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.57 -171.97 54.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 61.149999999999999 112.516 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -32.62 18.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.692 2.261 . . . . 74.329999999999998 112.266 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -91.17 -43.79 9.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 75.129999999999995 110.965 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.87 -93.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 75.420000000000002 112.515 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 81.04 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.7 2.267 . . . . 64.109999999999999 112.303 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.11 145.0 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 110.869 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.26 150.38 26.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.150000000000006 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.64 158.59 36.03 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 111.193 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -29.05 24.6 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.239 . . . . 73.319999999999993 112.37 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.868 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 121.417 0.454 . . . . 74.120000000000005 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.69 2.26 . . . . 70.120000000000005 112.343 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.37 149.63 24.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 110.855 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -140.99 139.8 20.12 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 73.319999999999993 110.836 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 79.58 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.409999999999997 112.306 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -150.5 178.88 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.878 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -171.97 54.23 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 50.409999999999997 112.469 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.54 18.41 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 71.209999999999994 112.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -91.16 -43.89 9.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 75.239999999999995 110.916 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.9 -93.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 72.310000000000002 112.506 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 81.35 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.656 2.237 . . . . 64.400000000000006 112.368 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 145.12 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 75.239999999999995 110.849 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.34 150.8 26.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.99 158.65 36.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.120000000000005 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -29.07 24.1 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.675 2.25 . . . . 73.439999999999998 112.295 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.5 110.895 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 121.43 0.461 . . . . 52.350000000000001 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -164.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 65.310000000000002 112.297 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.17 149.75 24.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.924 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.0 139.87 20.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.726 . . . . 73.209999999999994 110.894 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 79.98 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 72.340000000000003 112.323 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.1 mmt -150.97 178.7 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.439999999999998 110.88 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.8 -172.03 54.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 74.400000000000006 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.724 2.282 . . . . 74.129999999999995 112.355 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -91.32 -43.92 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.099999999999994 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.97 -93.85 0.63 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 71.140000000000001 112.49 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.28 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.627 2.218 . . . . 74.319999999999993 112.382 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.58 144.98 43.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.18 150.6 26.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 72.430000000000007 110.868 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.81 158.54 36.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.621 0.724 . . . . 73.409999999999997 111.152 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -29.04 24.86 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.685 2.257 . . . . 70.530000000000001 112.388 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.862 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.468 0.482 . . . . 74.409999999999997 112.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -164.83 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.698 2.265 . . . . 72.140000000000001 112.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.34 149.88 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 61.310000000000002 110.88 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -141.09 139.77 19.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.63 0.728 . . . . 71.409999999999997 110.862 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 79.92 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.708 2.272 . . . . 72.120000000000005 112.321 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.0 mtm -150.96 178.73 8.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 75.140000000000001 110.891 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.93 -172.05 54.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 62.210000000000001 112.458 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -32.39 18.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 74.239999999999995 112.346 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.5 -43.79 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.420000000000002 110.926 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 42.200000000000003 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 81.38 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.622 2.214 . . . . 72.329999999999998 112.338 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -115.61 145.21 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.340000000000003 110.955 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.52 150.68 26.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 53.340000000000003 110.846 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.94 158.58 36.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 73.230000000000004 111.073 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -29.13 24.84 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.734 2.289 . . . . 74.329999999999998 112.358 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 73.329999999999998 110.831 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.418 0.454 . . . . 74.319999999999993 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.88 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.656 2.238 . . . . 73.040000000000006 112.359 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.22 149.67 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.928 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -140.86 139.79 20.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.691 0.758 . . . . 75.340000000000003 110.924 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 79.97 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.249 . . . . 73.109999999999999 112.37 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.7 mmt -150.93 178.76 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 72.549999999999997 110.872 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.6 -172.05 54.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 54.549999999999997 112.493 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -32.66 18.53 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.759 2.306 . . . . 72.219999999999999 112.312 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -91.13 -43.86 9.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 110.882 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.96 -93.98 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.698 -0.763 . . . . 73.329999999999998 112.496 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 81.19 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 74.530000000000001 112.387 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.28 145.08 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.93 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.34 150.58 26.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.040000000000006 110.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.8 158.51 36.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.551 0.691 . . . . 64.150000000000006 111.176 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -29.07 25.0 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.709 2.273 . . . . 52.439999999999998 112.392 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 110.855 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.381 0.434 . . . . 44.32 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 64.329999999999998 112.353 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.32 150.17 24.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 73.120000000000005 110.898 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.5 139.89 19.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.631 0.729 . . . . 72.230000000000004 110.882 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 79.69 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.27 . . . . 72.140000000000001 112.3 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mtp -150.68 178.86 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.931 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.73 -171.95 54.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.792 -0.718 . . . . 74.549999999999997 112.508 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.673 2.248 . . . . 72.040000000000006 112.343 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -91.47 -43.85 9.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.214 -0.448 . . . . 73.230000000000004 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.99 -93.65 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 73.040000000000006 112.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 81.45 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.623 2.216 . . . . 71.349999999999994 112.371 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -115.87 145.54 42.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 72.450000000000003 110.882 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.79 150.97 26.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.129999999999995 110.854 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.11 158.64 36.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.694 0.759 . . . . 74.409999999999997 111.097 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.2 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 64.209999999999994 112.392 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 62.409999999999997 110.883 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.447 0.47 . . . . 74.299999999999997 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -164.81 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.633 2.222 . . . . 72.109999999999999 112.342 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.31 149.71 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.887 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -141.05 139.77 19.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.25 110.933 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 79.62 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 70.0 112.335 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.1 mmt -150.61 178.79 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 110.867 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -172.02 54.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 55.329999999999998 112.52 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 -32.55 18.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.666 2.244 . . . . 73.400000000000006 112.314 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -91.26 -43.81 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 71.519999999999996 110.954 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.81 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 74.099999999999994 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 81.38 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.711 2.274 . . . . 75.430000000000007 112.329 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -115.82 145.19 43.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 65.0 110.83 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.45 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.129999999999995 110.872 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.95 158.64 36.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 73.230000000000004 111.097 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -29.15 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 72.150000000000006 112.341 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.835 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 121.462 0.479 . . . . 55.520000000000003 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -164.86 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.694 2.263 . . . . 70.219999999999999 112.354 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.25 149.86 24.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -141.08 139.79 19.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.618 0.723 . . . . 72.200000000000003 110.88 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 80.15 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.678 2.252 . . . . 74.5 112.309 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm -151.14 178.64 9.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.847 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -172.04 54.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 73.420000000000002 112.44 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.4 18.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 74.120000000000005 112.353 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -91.38 -43.82 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 72.209999999999994 110.912 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.85 0.63 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.665 -0.779 . . . . 63.149999999999999 112.46 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 81.31 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.674 2.249 . . . . 74.310000000000002 112.414 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -115.52 144.95 43.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.948 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.8 m -107.22 150.51 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 110.825 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.75 158.61 36.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.653 0.739 . . . . 75.400000000000006 111.112 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.96 24.57 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.627 2.218 . . . . 72.140000000000001 112.348 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 75.140000000000001 110.867 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 121.372 0.429 . . . . 52.130000000000003 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -164.73 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.657 2.238 . . . . 74.549999999999997 112.329 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.7 150.55 23.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 72.140000000000001 110.88 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.05 140.01 18.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.629 0.728 . . . . 75.329999999999998 110.888 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 78.95 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.268 . . . . 75.430000000000007 112.33 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.4 mmt -149.58 179.04 8.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.129999999999995 110.95 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.42 -171.96 54.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.793 -0.718 . . . . 64.049999999999997 112.562 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.59 18.03 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.702 2.268 . . . . 75.430000000000007 112.346 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -90.98 -43.88 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 110.909 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 73.299999999999997 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 81.42 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.631 2.221 . . . . 72.510000000000005 112.346 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -115.99 146.31 42.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.230000000000004 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -108.45 151.16 26.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.049999999999997 110.858 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 pt -112.51 158.77 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.671 0.748 . . . . 72.329999999999998 111.089 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -29.34 23.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 73.239999999999995 112.364 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.409999999999997 110.877 179.88 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 CA-C-O 121.415 0.453 . . . . 51.340000000000003 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -163.52 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.676 2.251 . . . . 75.349999999999994 112.37 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.13 150.58 22.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -140.43 138.26 18.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.667 0.746 . . . . 72.400000000000006 110.811 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.63 0.88 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.693 2.262 . . . . 75.430000000000007 112.336 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.1 mtp -152.61 179.35 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.010000000000005 110.836 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.55 -171.87 54.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 72.450000000000003 112.438 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -32.72 18.51 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 72.219999999999999 112.35 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -91.19 -43.86 9.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 110.918 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 -94.42 0.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 62.130000000000003 112.54 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 80.62 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.7 2.267 . . . . 73.519999999999996 112.377 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.31 143.29 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 74.340000000000003 110.918 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.5 30.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 63.420000000000002 110.915 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.94 157.74 36.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.699 . . . . 72.040000000000006 111.167 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -28.33 25.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 72.040000000000006 112.314 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.814 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.438 0.466 . . . . 64.430000000000007 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -163.46 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.627 2.218 . . . . 74.540000000000006 112.354 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.3 m -101.23 150.41 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 110.918 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -140.17 138.23 19.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 65.030000000000001 110.927 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.695 2.263 . . . . 74.310000000000002 112.309 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.9 mtp -152.58 179.27 8.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 71.430000000000007 110.886 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.59 -171.85 54.2 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.67 18.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 70.099999999999994 112.316 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -91.18 -43.85 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.309 -0.405 . . . . 74.209999999999994 110.916 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.51 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 54.25 112.501 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 80.81 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.601 2.201 . . . . 62.43 112.399 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.35 143.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.787 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -106.78 146.53 30.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 54.009999999999998 110.851 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -109.01 157.82 35.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 74.239999999999995 111.106 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -28.48 25.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.65 2.233 . . . . 72.430000000000007 112.38 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 110.887 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 121.409 0.45 . . . . 64.140000000000001 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.5 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.728 2.285 . . . . 74.129999999999995 112.355 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.21 150.09 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.853 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -139.84 138.03 19.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.677 0.751 . . . . 74.519999999999996 110.908 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 80.66 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.69 2.26 . . . . 71.409999999999997 112.308 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.2 mtt -152.67 179.43 8.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.530000000000001 110.859 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.53 -171.8 54.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.773 -0.727 . . . . 73.239999999999995 112.492 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -32.52 18.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.651 2.234 . . . . 73.420000000000002 112.347 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.36 -43.83 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.91 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.76 -94.32 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.826 -0.702 . . . . 65.439999999999998 112.521 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 80.61 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.679 2.253 . . . . 73.219999999999999 112.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.18 143.02 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 74.010000000000005 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -106.8 146.23 31.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.844 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.67 157.72 35.94 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.563 0.697 . . . . 74.409999999999997 111.192 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -28.24 25.65 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 75.530000000000001 112.378 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 110.925 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.448 0.471 . . . . 41.329999999999998 112.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -163.43 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.678 2.252 . . . . 74.540000000000006 112.4 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.28 150.62 22.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 110.824 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -140.4 138.28 18.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.713 0.768 . . . . 75.109999999999999 110.836 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.68 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 74.310000000000002 112.304 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.3 mtp -152.65 179.34 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.853 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.61 -171.77 54.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.753 . . . . 50.229999999999997 112.516 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 -32.57 17.8 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 72.349999999999994 112.307 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.24 -43.88 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 73.120000000000005 110.896 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.86 -94.4 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 74.120000000000005 112.458 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.62 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.668 2.245 . . . . 75.319999999999993 112.342 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -113.19 143.29 44.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 71.239999999999995 110.938 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -107.02 146.56 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 72.519999999999996 110.897 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.93 157.86 35.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.719 . . . . 73.519999999999996 111.116 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -28.52 24.94 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.728 2.285 . . . . 74.0 112.291 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 73.129999999999995 110.895 179.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 121.474 0.486 . . . . 64.140000000000001 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 75.219999999999999 112.352 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.39 150.41 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.009999999999998 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -140.3 138.16 18.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.689 0.757 . . . . 72.319999999999993 110.887 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 79.89 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 70.329999999999998 112.343 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.9 mmm -151.5 179.52 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.36 -171.82 54.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 74.409999999999997 112.489 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -32.69 17.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 74.540000000000006 112.292 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -90.94 -43.93 9.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.879 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.66 -94.47 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.693 -0.765 . . . . 60.240000000000002 112.552 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 80.83 0.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.72 2.28 . . . . 74.349999999999994 112.294 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.59 143.31 44.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 63.009999999999998 110.952 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -107.0 146.68 30.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.832 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.11 157.89 35.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.634 0.73 . . . . 75.420000000000002 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -28.59 24.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.219 . . . . 75.209999999999994 112.371 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 110.849 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 121.431 0.462 . . . . 70.230000000000004 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.601 2.201 . . . . 73.25 112.331 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.27 149.88 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 110.927 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.75 138.08 19.44 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 75.120000000000005 110.887 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 79.88 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.281 . . . . 63.539999999999999 112.372 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 mmt -151.54 179.46 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 110.905 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.5 -171.87 54.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 74.230000000000004 112.504 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.67 18.17 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.607 2.205 . . . . 71.239999999999995 112.319 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -91.04 -43.85 9.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 73.439999999999998 110.978 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 62.200000000000003 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 81.0 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.612 2.208 . . . . 75.450000000000003 112.297 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.72 143.21 45.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 73.519999999999996 110.819 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.66 30.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 61.009999999999998 110.85 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.12 157.77 36.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 70.140000000000001 111.137 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -28.45 25.63 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.655 2.237 . . . . 71.430000000000007 112.415 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 110.803 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.463 0.479 . . . . 62.409999999999997 112.43 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -163.5 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.679 2.253 . . . . 74.129999999999995 112.365 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.44 149.63 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.039999999999999 110.828 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.42 137.76 19.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.589 0.709 . . . . 75.319999999999993 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 78.62 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 65.310000000000002 112.379 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -149.98 179.88 7.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.450000000000003 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.24 -172.01 54.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.681 -0.771 . . . . 62.420000000000002 112.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -32.81 17.46 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.287 . . . . 75.530000000000001 112.333 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -90.62 -43.86 9.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -94.71 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 64.430000000000007 112.516 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 80.63 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.674 2.25 . . . . 71.510000000000005 112.381 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.42 143.67 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.430000000000007 110.861 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.7 m -107.36 146.77 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 70.099999999999994 110.891 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.22 157.77 36.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 73.140000000000001 111.074 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -28.62 25.22 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.657 2.238 . . . . 75.430000000000007 112.354 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 63.450000000000003 110.931 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 121.431 0.462 . . . . 70.310000000000002 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.63 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.355 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.0 m -100.36 146.52 26.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.833 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -140.64 140.32 22.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.703 0.763 . . . . 73.420000000000002 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 77.55 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 73.310000000000002 112.269 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 31.1 mtt -143.54 -179.94 6.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.010000000000005 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.96 53.51 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.762 -0.732 . . . . 63.420000000000002 112.505 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -41.98 3.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 74.510000000000005 112.374 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -78.7 -43.97 24.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.899 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.02 -98.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 72.329999999999998 112.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 83.68 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.68 2.253 . . . . 75.530000000000001 112.371 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -118.62 144.69 45.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 110.944 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 10.0 m -101.67 145.36 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 64.239999999999995 110.846 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 pt -108.92 158.39 34.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.625 0.726 . . . . 75.099999999999994 111.147 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 -28.44 24.7 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 73.219999999999999 112.35 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 65.510000000000005 110.86 179.839 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 121.41 0.45 . . . . 73.420000000000002 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -163.57 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.247 . . . . 74.439999999999998 112.376 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.8 m -101.08 152.02 21.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 54.409999999999997 110.862 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.84 137.88 19.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.681 0.753 . . . . 74.049999999999997 110.866 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 78.18 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.714 2.276 . . . . 74.310000000000002 112.353 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 17.1 mtp -155.07 -178.98 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.933 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.88 -173.62 43.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 62.109999999999999 112.495 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.61 -17.91 37.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 73.120000000000005 112.464 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 -42.6 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 110.925 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.42 -87.91 0.43 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.716 -0.754 . . . . 72.150000000000006 112.493 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 86.28 0.58 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.752 2.302 . . . . 64.319999999999993 112.354 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -123.04 143.5 49.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.43 . . . . 72.540000000000006 110.824 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -111.19 146.72 36.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.349999999999994 110.929 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.65 157.28 36.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.598 0.713 . . . . 73.439999999999998 111.081 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -27.88 26.13 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.669 2.246 . . . . 71.239999999999995 112.371 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 65.409999999999997 110.877 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.414 0.452 . . . . 55.399999999999999 112.521 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -165.21 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.694 2.263 . . . . 73.0 112.328 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 1.8 m -104.3 155.81 18.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.899 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -145.05 139.86 15.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 73.099999999999994 110.834 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 78.53 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 64.230000000000004 112.285 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.58 179.69 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 110.835 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.58 -171.68 54.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 71.299999999999997 112.469 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -32.66 17.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 70.420000000000002 112.318 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -91.13 -43.96 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.409999999999997 110.902 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 75.099999999999994 112.457 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 81.17 0.82 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.729 2.286 . . . . 72.129999999999995 112.377 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -115.18 148.51 38.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 70.150000000000006 110.936 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.4 m -110.38 151.45 27.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.871 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.07 159.57 35.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.665 0.745 . . . . 71.340000000000003 111.1 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 107.93 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.693 2.262 . . . . 75.319999999999993 112.326 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.43 110.917 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.43 0.461 . . . . 64.010000000000005 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -164.82 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.681 2.254 . . . . 74.519999999999996 112.379 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.29 149.79 24.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 71.519999999999996 110.896 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -140.99 139.84 20.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.628 0.728 . . . . 73.239999999999995 110.861 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 80.08 0.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.686 2.258 . . . . 74.540000000000006 112.392 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.3 mtm -151.14 178.69 8.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.891 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.79 -172.02 54.16 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 63.119999999999997 112.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.42 18.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.74 2.293 . . . . 74.349999999999994 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -91.43 -43.85 9.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 74.150000000000006 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.79 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.773 -0.727 . . . . 72.439999999999998 112.509 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 81.37 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.653 2.235 . . . . 74.109999999999999 112.391 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 144.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.120000000000005 110.86 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.13 150.5 26.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.209999999999994 110.921 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.71 158.65 35.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.140000000000001 111.134 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -28.99 24.16 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.681 2.254 . . . . 74.329999999999998 112.339 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.929 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.406 0.448 . . . . 54.200000000000003 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.709 2.272 . . . . 75.219999999999999 112.324 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.16 149.93 24.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 73.530000000000001 110.849 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -141.14 139.74 19.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 75.109999999999999 110.837 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 80.22 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.725 2.283 . . . . 72.340000000000003 112.385 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 mtp -151.39 178.73 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 73.140000000000001 110.878 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.57 -171.97 54.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 61.149999999999999 112.516 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -32.62 18.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.692 2.261 . . . . 74.329999999999998 112.266 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -91.17 -43.79 9.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 75.129999999999995 110.965 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.87 -93.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 75.420000000000002 112.515 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 81.04 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.7 2.267 . . . . 64.109999999999999 112.303 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.11 145.0 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 110.869 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.26 150.38 26.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.150000000000006 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.64 158.59 36.03 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 111.193 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -29.05 24.6 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.239 . . . . 73.319999999999993 112.37 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.868 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 121.417 0.454 . . . . 74.120000000000005 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.69 2.26 . . . . 70.120000000000005 112.343 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.37 149.63 24.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 110.855 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -140.99 139.8 20.12 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 73.319999999999993 110.836 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 79.58 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.409999999999997 112.306 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -150.5 178.88 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.878 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -171.97 54.23 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 50.409999999999997 112.469 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.54 18.41 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 71.209999999999994 112.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -91.16 -43.89 9.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 75.239999999999995 110.916 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.9 -93.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 72.310000000000002 112.506 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 81.35 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.656 2.237 . . . . 64.400000000000006 112.368 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 145.12 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 75.239999999999995 110.849 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.34 150.8 26.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.99 158.65 36.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.120000000000005 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -29.07 24.1 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.675 2.25 . . . . 73.439999999999998 112.295 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.5 110.895 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 121.43 0.461 . . . . 52.350000000000001 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -164.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 65.310000000000002 112.297 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.17 149.75 24.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.924 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.0 139.87 20.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.726 . . . . 73.209999999999994 110.894 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 79.98 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 72.340000000000003 112.323 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.1 mmt -150.97 178.7 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.439999999999998 110.88 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.8 -172.03 54.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 74.400000000000006 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.724 2.282 . . . . 74.129999999999995 112.355 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -91.32 -43.92 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.099999999999994 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.97 -93.85 0.63 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 71.140000000000001 112.49 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.28 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.627 2.218 . . . . 74.319999999999993 112.382 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.58 144.98 43.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.18 150.6 26.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 72.430000000000007 110.868 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.81 158.54 36.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.621 0.724 . . . . 73.409999999999997 111.152 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -29.04 24.86 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.685 2.257 . . . . 70.530000000000001 112.388 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.862 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.468 0.482 . . . . 74.409999999999997 112.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -164.83 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.698 2.265 . . . . 72.140000000000001 112.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.34 149.88 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 61.310000000000002 110.88 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -141.09 139.77 19.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.63 0.728 . . . . 71.409999999999997 110.862 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 79.92 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.708 2.272 . . . . 72.120000000000005 112.321 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.0 mtm -150.96 178.73 8.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 75.140000000000001 110.891 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.93 -172.05 54.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 62.210000000000001 112.458 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -32.39 18.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 74.239999999999995 112.346 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.5 -43.79 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.420000000000002 110.926 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 42.200000000000003 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 81.38 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.622 2.214 . . . . 72.329999999999998 112.338 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -115.61 145.21 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.340000000000003 110.955 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.52 150.68 26.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 53.340000000000003 110.846 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.94 158.58 36.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 73.230000000000004 111.073 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -29.13 24.84 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.734 2.289 . . . . 74.329999999999998 112.358 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 73.329999999999998 110.831 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.418 0.454 . . . . 74.319999999999993 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.88 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.656 2.238 . . . . 73.040000000000006 112.359 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.22 149.67 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.928 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -140.86 139.79 20.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.691 0.758 . . . . 75.340000000000003 110.924 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 79.97 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.249 . . . . 73.109999999999999 112.37 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.7 mmt -150.93 178.76 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 72.549999999999997 110.872 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.6 -172.05 54.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 54.549999999999997 112.493 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -32.66 18.53 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.759 2.306 . . . . 72.219999999999999 112.312 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -91.13 -43.86 9.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 110.882 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.96 -93.98 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.698 -0.763 . . . . 73.329999999999998 112.496 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 81.19 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 74.530000000000001 112.387 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.28 145.08 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.93 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.34 150.58 26.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.040000000000006 110.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.8 158.51 36.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.551 0.691 . . . . 64.150000000000006 111.176 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -29.07 25.0 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.709 2.273 . . . . 52.439999999999998 112.392 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 110.855 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.381 0.434 . . . . 44.32 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 64.329999999999998 112.353 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.32 150.17 24.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 73.120000000000005 110.898 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.5 139.89 19.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.631 0.729 . . . . 72.230000000000004 110.882 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 79.69 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.27 . . . . 72.140000000000001 112.3 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mtp -150.68 178.86 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.931 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.73 -171.95 54.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.792 -0.718 . . . . 74.549999999999997 112.508 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.673 2.248 . . . . 72.040000000000006 112.343 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -91.47 -43.85 9.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.214 -0.448 . . . . 73.230000000000004 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.99 -93.65 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 73.040000000000006 112.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 81.45 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.623 2.216 . . . . 71.349999999999994 112.371 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -115.87 145.54 42.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 72.450000000000003 110.882 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.79 150.97 26.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.129999999999995 110.854 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.11 158.64 36.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.694 0.759 . . . . 74.409999999999997 111.097 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.2 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 64.209999999999994 112.392 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 62.409999999999997 110.883 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.447 0.47 . . . . 74.299999999999997 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -164.81 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.633 2.222 . . . . 72.109999999999999 112.342 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.31 149.71 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.887 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -141.05 139.77 19.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.25 110.933 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 79.62 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 70.0 112.335 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.1 mmt -150.61 178.79 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 110.867 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -172.02 54.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 55.329999999999998 112.52 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 -32.55 18.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.666 2.244 . . . . 73.400000000000006 112.314 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -91.26 -43.81 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 71.519999999999996 110.954 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.81 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 74.099999999999994 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 81.38 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.711 2.274 . . . . 75.430000000000007 112.329 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -115.82 145.19 43.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 65.0 110.83 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.45 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.129999999999995 110.872 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.95 158.64 36.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 73.230000000000004 111.097 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -29.15 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 72.150000000000006 112.341 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.835 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 121.462 0.479 . . . . 55.520000000000003 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -164.86 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.694 2.263 . . . . 70.219999999999999 112.354 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.25 149.86 24.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -141.08 139.79 19.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.618 0.723 . . . . 72.200000000000003 110.88 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 80.15 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.678 2.252 . . . . 74.5 112.309 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm -151.14 178.64 9.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.847 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -172.04 54.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 73.420000000000002 112.44 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.4 18.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 74.120000000000005 112.353 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -91.38 -43.82 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 72.209999999999994 110.912 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.85 0.63 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.665 -0.779 . . . . 63.149999999999999 112.46 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 81.31 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.674 2.249 . . . . 74.310000000000002 112.414 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -115.52 144.95 43.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.948 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.8 m -107.22 150.51 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 110.825 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.75 158.61 36.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.653 0.739 . . . . 75.400000000000006 111.112 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.96 24.57 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.627 2.218 . . . . 72.140000000000001 112.348 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 75.140000000000001 110.867 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 121.372 0.429 . . . . 52.130000000000003 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -164.73 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.657 2.238 . . . . 74.549999999999997 112.329 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.7 150.55 23.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 72.140000000000001 110.88 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.05 140.01 18.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.629 0.728 . . . . 75.329999999999998 110.888 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 78.95 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.268 . . . . 75.430000000000007 112.33 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.4 mmt -149.58 179.04 8.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.129999999999995 110.95 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.42 -171.96 54.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.793 -0.718 . . . . 64.049999999999997 112.562 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.59 18.03 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.702 2.268 . . . . 75.430000000000007 112.346 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -90.98 -43.88 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 110.909 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 73.299999999999997 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 81.42 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.631 2.221 . . . . 72.510000000000005 112.346 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -115.99 146.31 42.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.230000000000004 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -108.45 151.16 26.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.049999999999997 110.858 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 pt -112.51 158.77 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.671 0.748 . . . . 72.329999999999998 111.089 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -29.34 23.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 73.239999999999995 112.364 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.409999999999997 110.877 179.88 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 CA-C-O 121.415 0.453 . . . . 51.340000000000003 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -163.52 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.676 2.251 . . . . 75.349999999999994 112.37 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.13 150.58 22.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -140.43 138.26 18.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.667 0.746 . . . . 72.400000000000006 110.811 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.63 0.88 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.693 2.262 . . . . 75.430000000000007 112.336 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.1 mtp -152.61 179.35 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.010000000000005 110.836 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.55 -171.87 54.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 72.450000000000003 112.438 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -32.72 18.51 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 72.219999999999999 112.35 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -91.19 -43.86 9.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 110.918 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 -94.42 0.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 62.130000000000003 112.54 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 80.62 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.7 2.267 . . . . 73.519999999999996 112.377 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.31 143.29 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 74.340000000000003 110.918 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.5 30.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 63.420000000000002 110.915 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.94 157.74 36.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.699 . . . . 72.040000000000006 111.167 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -28.33 25.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 72.040000000000006 112.314 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.814 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.438 0.466 . . . . 64.430000000000007 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -163.46 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.627 2.218 . . . . 74.540000000000006 112.354 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.3 m -101.23 150.41 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 110.918 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -140.17 138.23 19.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 65.030000000000001 110.927 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.695 2.263 . . . . 74.310000000000002 112.309 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.9 mtp -152.58 179.27 8.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 71.430000000000007 110.886 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.59 -171.85 54.2 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.67 18.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 70.099999999999994 112.316 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -91.18 -43.85 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.309 -0.405 . . . . 74.209999999999994 110.916 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.51 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 54.25 112.501 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 80.81 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.601 2.201 . . . . 62.43 112.399 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.35 143.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.787 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -106.78 146.53 30.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 54.009999999999998 110.851 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -109.01 157.82 35.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 74.239999999999995 111.106 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -28.48 25.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.65 2.233 . . . . 72.430000000000007 112.38 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 110.887 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 121.409 0.45 . . . . 64.140000000000001 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.5 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.728 2.285 . . . . 74.129999999999995 112.355 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.21 150.09 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.853 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -139.84 138.03 19.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.677 0.751 . . . . 74.519999999999996 110.908 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 80.66 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.69 2.26 . . . . 71.409999999999997 112.308 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.2 mtt -152.67 179.43 8.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.530000000000001 110.859 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.53 -171.8 54.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.773 -0.727 . . . . 73.239999999999995 112.492 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -32.52 18.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.651 2.234 . . . . 73.420000000000002 112.347 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.36 -43.83 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.91 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.76 -94.32 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.826 -0.702 . . . . 65.439999999999998 112.521 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 80.61 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.679 2.253 . . . . 73.219999999999999 112.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.18 143.02 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 74.010000000000005 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -106.8 146.23 31.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.844 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.67 157.72 35.94 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.563 0.697 . . . . 74.409999999999997 111.192 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -28.24 25.65 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 75.530000000000001 112.378 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 110.925 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.448 0.471 . . . . 41.329999999999998 112.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -163.43 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.678 2.252 . . . . 74.540000000000006 112.4 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.28 150.62 22.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 110.824 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -140.4 138.28 18.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.713 0.768 . . . . 75.109999999999999 110.836 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.68 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 74.310000000000002 112.304 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.3 mtp -152.65 179.34 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.853 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.61 -171.77 54.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.753 . . . . 50.229999999999997 112.516 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 -32.57 17.8 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 72.349999999999994 112.307 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.24 -43.88 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 73.120000000000005 110.896 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.86 -94.4 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 74.120000000000005 112.458 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.62 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.668 2.245 . . . . 75.319999999999993 112.342 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -113.19 143.29 44.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 71.239999999999995 110.938 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -107.02 146.56 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 72.519999999999996 110.897 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.93 157.86 35.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.719 . . . . 73.519999999999996 111.116 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -28.52 24.94 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.728 2.285 . . . . 74.0 112.291 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 73.129999999999995 110.895 179.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 121.474 0.486 . . . . 64.140000000000001 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 75.219999999999999 112.352 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.39 150.41 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.009999999999998 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -140.3 138.16 18.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.689 0.757 . . . . 72.319999999999993 110.887 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 79.89 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 70.329999999999998 112.343 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.9 mmm -151.5 179.52 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.36 -171.82 54.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 74.409999999999997 112.489 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -32.69 17.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 74.540000000000006 112.292 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -90.94 -43.93 9.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.879 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.66 -94.47 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.693 -0.765 . . . . 60.240000000000002 112.552 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 80.83 0.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.72 2.28 . . . . 74.349999999999994 112.294 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.59 143.31 44.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 63.009999999999998 110.952 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -107.0 146.68 30.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.832 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.11 157.89 35.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.634 0.73 . . . . 75.420000000000002 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -28.59 24.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.219 . . . . 75.209999999999994 112.371 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 110.849 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 121.431 0.462 . . . . 70.230000000000004 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.601 2.201 . . . . 73.25 112.331 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.27 149.88 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 110.927 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.75 138.08 19.44 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 75.120000000000005 110.887 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 79.88 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.281 . . . . 63.539999999999999 112.372 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 mmt -151.54 179.46 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 110.905 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.5 -171.87 54.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 74.230000000000004 112.504 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.67 18.17 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.607 2.205 . . . . 71.239999999999995 112.319 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -91.04 -43.85 9.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 73.439999999999998 110.978 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 62.200000000000003 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 81.0 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.612 2.208 . . . . 75.450000000000003 112.297 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.72 143.21 45.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 73.519999999999996 110.819 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.66 30.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 61.009999999999998 110.85 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.12 157.77 36.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 70.140000000000001 111.137 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -28.45 25.63 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.655 2.237 . . . . 71.430000000000007 112.415 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 110.803 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.463 0.479 . . . . 62.409999999999997 112.43 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -163.5 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.679 2.253 . . . . 74.129999999999995 112.365 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.44 149.63 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.039999999999999 110.828 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.42 137.76 19.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.589 0.709 . . . . 75.319999999999993 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 78.62 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 65.310000000000002 112.379 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -149.98 179.88 7.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.450000000000003 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.24 -172.01 54.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.681 -0.771 . . . . 62.420000000000002 112.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -32.81 17.46 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.287 . . . . 75.530000000000001 112.333 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -90.62 -43.86 9.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -94.71 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 64.430000000000007 112.516 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 80.63 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.674 2.25 . . . . 71.510000000000005 112.381 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.42 143.67 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.430000000000007 110.861 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.7 m -107.36 146.77 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 70.099999999999994 110.891 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.22 157.77 36.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 73.140000000000001 111.074 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -28.62 25.22 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.657 2.238 . . . . 75.430000000000007 112.354 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 63.450000000000003 110.931 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 121.431 0.462 . . . . 70.310000000000002 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.63 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.355 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.0 m -100.36 146.52 26.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.833 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -140.64 140.32 22.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.703 0.763 . . . . 73.420000000000002 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 77.55 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 73.310000000000002 112.269 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 31.1 mtt -143.54 -179.94 6.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.010000000000005 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.96 53.51 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.762 -0.732 . . . . 63.420000000000002 112.505 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -41.98 3.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 74.510000000000005 112.374 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -78.7 -43.97 24.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.899 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.02 -98.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 72.329999999999998 112.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 83.68 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.68 2.253 . . . . 75.530000000000001 112.371 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -118.62 144.69 45.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 110.944 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 10.0 m -101.67 145.36 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 64.239999999999995 110.846 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 pt -108.92 158.39 34.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.625 0.726 . . . . 75.099999999999994 111.147 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 -28.44 24.7 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 73.219999999999999 112.35 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 65.510000000000005 110.86 179.839 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 121.41 0.45 . . . . 73.420000000000002 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -163.57 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.247 . . . . 74.439999999999998 112.376 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.8 m -101.08 152.02 21.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 54.409999999999997 110.862 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.84 137.88 19.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.681 0.753 . . . . 74.049999999999997 110.866 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 78.18 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.714 2.276 . . . . 74.310000000000002 112.353 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 17.1 mtp -155.07 -178.98 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.933 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.88 -173.62 43.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 62.109999999999999 112.495 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.61 -17.91 37.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 73.120000000000005 112.464 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 -42.6 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 110.925 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.42 -87.91 0.43 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.716 -0.754 . . . . 72.150000000000006 112.493 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 86.28 0.58 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.752 2.302 . . . . 64.319999999999993 112.354 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -123.04 143.5 49.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.43 . . . . 72.540000000000006 110.824 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -111.19 146.72 36.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.349999999999994 110.929 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.65 157.28 36.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.598 0.713 . . . . 73.439999999999998 111.081 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -27.88 26.13 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.669 2.246 . . . . 71.239999999999995 112.371 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 65.409999999999997 110.877 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.414 0.452 . . . . 55.399999999999999 112.521 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -165.21 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.694 2.263 . . . . 73.0 112.328 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 1.8 m -104.3 155.81 18.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.899 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -145.05 139.86 15.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 73.099999999999994 110.834 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 78.53 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 64.230000000000004 112.285 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.58 179.69 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 110.835 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.58 -171.68 54.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 71.299999999999997 112.469 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -32.66 17.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 70.420000000000002 112.318 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -91.13 -43.96 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.409999999999997 110.902 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 75.099999999999994 112.457 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 81.17 0.82 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.729 2.286 . . . . 72.129999999999995 112.377 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -115.18 148.51 38.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 70.150000000000006 110.936 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.4 m -110.38 151.45 27.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.871 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.07 159.57 35.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.665 0.745 . . . . 71.340000000000003 111.1 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 107.93 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.693 2.262 . . . . 75.319999999999993 112.326 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.43 110.917 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.43 0.461 . . . . 64.01 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -164.82 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.681 2.254 . . . . 62.44 112.379 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.29 149.79 24.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 53.1 110.896 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -140.99 139.84 20.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.628 0.728 . . . . 55.04 110.861 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 80.08 0.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.686 2.258 . . . . 74.54 112.392 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.3 mtm -151.14 178.69 8.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.891 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.79 -172.02 54.16 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 63.12 112.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.42 18.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.74 2.293 . . . . 74.35 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -91.43 -43.85 9.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.79 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.773 -0.727 . . . . 72.44 112.509 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 81.37 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.653 2.235 . . . . 74.11 112.391 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 144.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.86 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.13 150.5 26.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.21 110.921 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.71 158.65 35.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 73.52 111.134 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -28.99 24.16 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.681 2.254 . . . . 72.44 112.339 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 64.3 110.929 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.406 0.448 . . . . 54.2 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.709 2.272 . . . . 75.22 112.324 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.16 149.93 24.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 64.32 110.849 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -141.14 139.74 19.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 75.11 110.837 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 80.22 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.725 2.283 . . . . 63.45 112.385 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 mtp -151.39 178.73 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 73.14 110.878 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.57 -171.97 54.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 53.31 112.516 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -32.62 18.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.692 2.261 . . . . 74.33 112.266 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -91.17 -43.79 9.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.965 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.87 -93.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 75.42 112.515 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 81.04 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.7 2.267 . . . . 64.11 112.303 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.11 145.0 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.04 110.869 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.26 150.38 26.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 62.25 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.64 158.59 36.03 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.579 0.704 . . . . 71.53 111.193 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -29.05 24.6 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.239 . . . . 73.32 112.37 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.868 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 121.417 0.454 . . . . 65.14 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.69 2.26 . . . . 62.43 112.343 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.37 149.63 24.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 72.03 110.855 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -140.99 139.8 20.12 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 73.32 110.836 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 79.58 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.41 112.306 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -150.5 178.88 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 61.21 110.878 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -171.97 54.23 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 50.41 112.469 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.54 18.41 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 55.31 112.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -91.16 -43.89 9.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 75.24 110.916 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.9 -93.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 71.4 112.506 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 81.35 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.656 2.237 . . . . 61.25 112.368 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 145.12 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.849 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.34 150.8 26.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.99 158.65 36.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.03 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -29.07 24.1 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.675 2.25 . . . . 73.14 112.295 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.5 110.895 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 121.43 0.461 . . . . 50.14 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -164.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 63.23 112.297 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.17 149.75 24.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.924 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.0 139.87 20.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.726 . . . . 73.21 110.894 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 79.98 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 72.34 112.323 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.1 mmt -150.97 178.7 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.88 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.8 -172.03 54.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 74.4 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.724 2.282 . . . . 74.13 112.355 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -91.32 -43.92 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.97 -93.85 0.63 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 63.22 112.49 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.28 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.627 2.218 . . . . 74.32 112.382 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.58 144.98 43.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 55.14 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.18 150.6 26.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.868 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.81 158.54 36.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.621 0.724 . . . . 73.41 111.152 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -29.04 24.86 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.685 2.257 . . . . 70.32 112.388 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.862 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.468 0.482 . . . . 54.23 112.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -164.83 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.698 2.265 . . . . 72.14 112.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.34 149.88 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 61.31 110.88 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -141.09 139.77 19.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.63 0.728 . . . . 71.21 110.862 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 79.92 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.708 2.272 . . . . 72.12 112.321 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.0 mtm -150.96 178.73 8.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 70.13 110.891 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.93 -172.05 54.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 33.45 112.458 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -32.39 18.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 74.24 112.346 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.5 -43.79 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.926 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 21.22 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 81.38 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.622 2.214 . . . . 72.33 112.338 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -115.61 145.21 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.955 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.52 150.68 26.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 53.34 110.846 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.94 158.58 36.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 73.03 111.073 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -29.13 24.84 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.734 2.289 . . . . 71.14 112.358 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.831 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.418 0.454 . . . . 74.32 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.88 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.656 2.238 . . . . 73.04 112.359 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.22 149.67 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.928 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -140.86 139.79 20.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.691 0.758 . . . . 54.02 110.924 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 79.97 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.249 . . . . 72.21 112.37 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.7 mmt -150.93 178.76 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 72.55 110.872 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.6 -172.05 54.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 51.24 112.493 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -32.66 18.53 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.759 2.306 . . . . 54.35 112.312 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -91.13 -43.86 9.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.11 110.882 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.96 -93.98 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.698 -0.763 . . . . 70.44 112.496 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 81.19 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 74.53 112.387 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.28 145.08 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 62.24 110.93 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.34 150.58 26.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.04 110.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.8 158.51 36.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.551 0.691 . . . . 64.15 111.176 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -29.07 25.0 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.709 2.273 . . . . 52.44 112.392 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.855 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.381 0.434 . . . . 44.13 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 64.33 112.353 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.32 150.17 24.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 64.21 110.898 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.5 139.89 19.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.631 0.729 . . . . 71.22 110.882 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 79.69 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.27 . . . . 62.53 112.3 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mtp -150.68 178.86 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.931 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.73 -171.95 54.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.508 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.673 2.248 . . . . 72.04 112.343 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -91.47 -43.85 9.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.99 -93.65 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 73.04 112.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 81.45 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.623 2.216 . . . . 71.2 112.371 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -115.87 145.54 42.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 72.45 110.882 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.79 150.97 26.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.13 110.854 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.11 158.64 36.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.694 0.759 . . . . 71.02 111.097 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.2 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 64.21 112.392 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 62.41 110.883 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.447 0.47 . . . . 62.3 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -164.81 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.633 2.222 . . . . 72.11 112.342 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.31 149.71 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 55.3 110.887 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -141.05 139.77 19.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.25 110.933 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 79.62 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 64.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.1 mmt -150.61 178.79 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 74.11 110.867 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -172.02 54.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 54.02 112.52 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 -32.55 18.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.666 2.244 . . . . 73.4 112.314 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -91.26 -43.81 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.954 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.81 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 25.13 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 81.38 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.711 2.274 . . . . 72.14 112.329 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -115.82 145.19 43.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 65.0 110.83 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.45 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.13 110.872 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.95 158.64 36.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 42.43 111.097 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -29.15 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 72.15 112.341 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.835 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 121.462 0.479 . . . . 51.32 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -164.86 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.694 2.263 . . . . 63.41 112.354 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.25 149.86 24.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.13 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -141.08 139.79 19.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.618 0.723 . . . . 72.2 110.88 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 80.15 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.678 2.252 . . . . 74.5 112.309 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm -151.14 178.64 9.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.55 110.847 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -172.04 54.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 73.13 112.44 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.4 18.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 64.33 112.353 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -91.38 -43.82 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 72.21 110.912 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.85 0.63 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.665 -0.779 . . . . 62.25 112.46 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 81.31 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.674 2.249 . . . . 53.01 112.414 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -115.52 144.95 43.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.948 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.8 m -107.22 150.51 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.825 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.75 158.61 36.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.653 0.739 . . . . 72.34 111.112 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.96 24.57 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.627 2.218 . . . . 71.42 112.348 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.867 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 121.372 0.429 . . . . 50.25 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -164.73 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.657 2.238 . . . . 74.55 112.329 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.7 150.55 23.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 53.03 110.88 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.05 140.01 18.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.629 0.728 . . . . 75.33 110.888 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 78.95 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.268 . . . . 75.43 112.33 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.4 mmt -149.58 179.04 8.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.95 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.42 -171.96 54.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.793 -0.718 . . . . 43.13 112.562 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.59 18.03 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.702 2.268 . . . . 75.43 112.346 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -90.98 -43.88 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.909 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 73.3 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 81.42 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.631 2.221 . . . . 64.12 112.346 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -115.99 146.31 42.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.23 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -108.45 151.16 26.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.05 110.858 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 pt -112.51 158.77 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.671 0.748 . . . . 60.42 111.089 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -29.34 23.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 73.24 112.364 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.41 110.877 179.88 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 CA-C-O 121.415 0.453 . . . . 44.44 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -163.52 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.676 2.251 . . . . 64.14 112.37 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.13 150.58 22.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -140.43 138.26 18.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.667 0.746 . . . . 72.4 110.811 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.63 0.88 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.693 2.262 . . . . 75.41 112.336 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.1 mtp -152.61 179.35 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.01 110.836 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.55 -171.87 54.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 72.45 112.438 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -32.72 18.51 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 72.22 112.35 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -91.19 -43.86 9.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 -94.42 0.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 62.13 112.54 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 80.62 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.7 2.267 . . . . 73.52 112.377 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.31 143.29 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 74.34 110.918 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.5 30.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 54.51 110.915 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.94 157.74 36.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.699 . . . . 61.01 111.167 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -28.33 25.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 71.32 112.314 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.814 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.438 0.466 . . . . 62.34 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -163.46 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.627 2.218 . . . . 74.54 112.354 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.3 m -101.23 150.41 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.918 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -140.17 138.23 19.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 64.43 110.927 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.695 2.263 . . . . 40.02 112.309 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.9 mtp -152.58 179.27 8.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 71.43 110.886 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.59 -171.85 54.2 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.67 18.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 70.1 112.316 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -91.18 -43.85 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.309 -0.405 . . . . 73.24 110.916 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.51 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 54.25 112.501 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 80.81 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.601 2.201 . . . . 62.43 112.399 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.35 143.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.787 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -106.78 146.53 30.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 50.23 110.851 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -109.01 157.82 35.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 72.41 111.106 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -28.48 25.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.65 2.233 . . . . 53.41 112.38 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.887 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 121.409 0.45 . . . . 64.14 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.5 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.728 2.285 . . . . 74.04 112.355 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.21 150.09 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.853 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -139.84 138.03 19.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.677 0.751 . . . . 74.52 110.908 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 80.66 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.69 2.26 . . . . 52.42 112.308 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.2 mtt -152.67 179.43 8.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.859 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.53 -171.8 54.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.773 -0.727 . . . . 73.24 112.492 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -32.52 18.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.651 2.234 . . . . 54.54 112.347 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.36 -43.83 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 65.34 110.91 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.76 -94.32 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.826 -0.702 . . . . 65.44 112.521 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 80.61 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.679 2.253 . . . . 73.22 112.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.18 143.02 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 63.44 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -106.8 146.23 31.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.844 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.67 157.72 35.94 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.563 0.697 . . . . 74.41 111.192 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -28.24 25.65 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 64.42 112.378 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.925 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.448 0.471 . . . . 21.01 112.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -163.43 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.678 2.252 . . . . 74.54 112.4 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.28 150.62 22.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 71.11 110.824 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -140.4 138.28 18.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.713 0.768 . . . . 74.43 110.836 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.68 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 54.11 112.304 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.3 mtp -152.65 179.34 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 64.0 110.853 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.61 -171.77 54.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.753 . . . . 34.42 112.516 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 -32.57 17.8 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.41 112.307 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.24 -43.88 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.896 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.86 -94.4 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 64.52 112.458 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.62 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.668 2.245 . . . . 71.42 112.342 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -113.19 143.29 44.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 71.24 110.938 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -107.02 146.56 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 72.52 110.897 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.93 157.86 35.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.719 . . . . 73.52 111.116 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -28.52 24.94 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.728 2.285 . . . . 65.44 112.291 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.895 179.934 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 121.474 0.486 . . . . 21.23 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 75.22 112.352 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.39 150.41 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.01 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -140.3 138.16 18.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.689 0.757 . . . . 71.23 110.887 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 79.89 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 70.33 112.343 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.9 mmm -151.5 179.52 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.36 -171.82 54.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 42.21 112.489 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -32.69 17.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 54.5 112.292 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -90.94 -43.93 9.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.879 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.66 -94.47 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.693 -0.765 . . . . 60.24 112.552 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 80.83 0.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.72 2.28 . . . . 74.35 112.294 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.59 143.31 44.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 63.01 110.952 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -107.0 146.68 30.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.832 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.11 157.89 35.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.634 0.73 . . . . 75.42 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -28.59 24.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.219 . . . . 62.4 112.371 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.849 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 121.431 0.462 . . . . 70.23 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.601 2.201 . . . . 73.25 112.331 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.27 149.88 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.927 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.75 138.08 19.44 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 75.12 110.887 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 79.88 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.281 . . . . 63.32 112.372 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 mmt -151.54 179.46 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.905 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.5 -171.87 54.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 74.23 112.504 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.67 18.17 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.607 2.205 . . . . 63.42 112.319 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -91.04 -43.85 9.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 73.44 110.978 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 51.41 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 81.0 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.612 2.208 . . . . 75.45 112.297 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.72 143.21 45.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 65.54 110.819 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.66 30.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 61.01 110.85 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.12 157.77 36.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 61.3 111.137 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -28.45 25.63 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.655 2.237 . . . . 70.52 112.415 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 71.11 110.803 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.463 0.479 . . . . 62.41 112.43 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -163.5 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.679 2.253 . . . . 70.52 112.365 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.44 149.63 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.04 110.828 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.42 137.76 19.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.589 0.709 . . . . 73.42 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 78.62 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 65.31 112.379 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -149.98 179.88 7.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.45 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.24 -172.01 54.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.681 -0.771 . . . . 62.42 112.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -32.81 17.46 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.287 . . . . 73.23 112.333 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -90.62 -43.86 9.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.41 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -94.71 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 64.43 112.516 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 80.63 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.674 2.25 . . . . 71.51 112.381 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.42 143.67 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.43 110.861 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.7 m -107.36 146.77 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 52.41 110.891 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.22 157.77 36.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 71.15 111.074 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -28.62 25.22 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.657 2.238 . . . . 71.15 112.354 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.931 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 121.431 0.462 . . . . 54.2 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.63 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.674 2.249 . . . . 72.14 112.355 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.0 m -100.36 146.52 26.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.833 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -140.64 140.32 22.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.703 0.763 . . . . 72.31 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 77.55 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 52.21 112.269 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 31.1 mtt -143.54 -179.94 6.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.96 53.51 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.762 -0.732 . . . . 34.02 112.505 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -41.98 3.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 74.51 112.374 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -78.7 -43.97 24.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.3 110.899 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.02 -98.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 72.33 112.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 83.68 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.68 2.253 . . . . 73.32 112.371 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -118.62 144.69 45.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.944 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 10.0 m -101.67 145.36 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 64.24 110.846 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 pt -108.92 158.39 34.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.625 0.726 . . . . 64.54 111.147 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 -28.44 24.7 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 73.22 112.35 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 62.3 110.86 179.839 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 121.41 0.45 . . . . 73.42 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -163.57 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.247 . . . . 74.44 112.376 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.8 m -101.08 152.02 21.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 54.41 110.862 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.84 137.88 19.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.681 0.753 . . . . 74.05 110.866 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 78.18 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.714 2.276 . . . . 74.31 112.353 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 17.1 mtp -155.07 -178.98 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.933 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.88 -173.62 43.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 55.21 112.495 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.61 -17.91 37.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 73.12 112.464 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 -42.6 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 74.44 110.925 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.42 -87.91 0.43 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.716 -0.754 . . . . 72.15 112.493 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 86.28 0.58 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.752 2.302 . . . . 52.4 112.354 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -123.04 143.5 49.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.43 . . . . 64.34 110.824 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -111.19 146.72 36.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.35 110.929 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.65 157.28 36.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.598 0.713 . . . . 73.12 111.081 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -27.88 26.13 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.669 2.246 . . . . 71.24 112.371 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.877 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.414 0.452 . . . . 23.33 112.521 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -165.21 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.694 2.263 . . . . 72.41 112.328 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 1.8 m -104.3 155.81 18.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 73.2 110.899 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -145.05 139.86 15.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 62.23 110.834 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 78.53 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 62.22 112.285 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.58 179.69 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.11 110.835 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.58 -171.68 54.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 65.11 112.469 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -32.66 17.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 70.42 112.318 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -91.13 -43.96 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.41 110.902 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 75.1 112.457 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 81.17 0.82 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.729 2.286 . . . . 71.12 112.377 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HE1' HG23 ' A' ' 14' ' ' ILE . 14.1 p90 -115.18 148.51 38.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 70.15 110.936 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.4 m -110.38 151.45 27.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 73.4 110.871 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HE1' ' A' ' 12' ' ' PHE . 2.4 pt -114.07 159.57 35.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.665 0.745 . . . . 64.2 111.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 107.93 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.693 2.262 . . . . 75.32 112.326 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.43 110.917 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.43 0.461 . . . . 64.01 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -164.82 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.681 2.254 . . . . 62.44 112.379 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.29 149.79 24.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 53.1 110.896 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -140.99 139.84 20.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.628 0.728 . . . . 55.04 110.861 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 80.08 0.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.686 2.258 . . . . 74.54 112.392 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.3 mtm -151.14 178.69 8.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.891 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.79 -172.02 54.16 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 63.12 112.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.42 18.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.74 2.293 . . . . 74.35 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -91.43 -43.85 9.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.79 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.773 -0.727 . . . . 72.44 112.509 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 81.37 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.653 2.235 . . . . 74.11 112.391 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 144.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.86 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.13 150.5 26.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.21 110.921 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.71 158.65 35.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 73.52 111.134 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -28.99 24.16 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.681 2.254 . . . . 72.44 112.339 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 64.3 110.929 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.406 0.448 . . . . 54.2 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.709 2.272 . . . . 75.22 112.324 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.16 149.93 24.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 64.32 110.849 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -141.14 139.74 19.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 75.11 110.837 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 80.22 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.725 2.283 . . . . 63.45 112.385 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 mtp -151.39 178.73 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 73.14 110.878 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.57 -171.97 54.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 53.31 112.516 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -32.62 18.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.692 2.261 . . . . 74.33 112.266 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -91.17 -43.79 9.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.965 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.87 -93.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 75.42 112.515 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 81.04 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.7 2.267 . . . . 64.11 112.303 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.11 145.0 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.04 110.869 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.26 150.38 26.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 62.25 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.64 158.59 36.03 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.579 0.704 . . . . 71.53 111.193 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -29.05 24.6 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.239 . . . . 73.32 112.37 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.868 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 121.417 0.454 . . . . 65.14 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.69 2.26 . . . . 62.43 112.343 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.37 149.63 24.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 72.03 110.855 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -140.99 139.8 20.12 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 73.32 110.836 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 79.58 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.41 112.306 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -150.5 178.88 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 61.21 110.878 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -171.97 54.23 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 50.41 112.469 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.54 18.41 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 55.31 112.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -91.16 -43.89 9.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 75.24 110.916 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.9 -93.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 71.4 112.506 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 81.35 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.656 2.237 . . . . 61.25 112.368 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 145.12 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.849 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.34 150.8 26.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.99 158.65 36.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.03 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -29.07 24.1 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.675 2.25 . . . . 73.14 112.295 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.5 110.895 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 121.43 0.461 . . . . 50.14 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -164.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 63.23 112.297 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.17 149.75 24.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.924 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.0 139.87 20.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.726 . . . . 73.21 110.894 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 79.98 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 72.34 112.323 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.1 mmt -150.97 178.7 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.88 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.8 -172.03 54.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 74.4 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.724 2.282 . . . . 74.13 112.355 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -91.32 -43.92 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.97 -93.85 0.63 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 63.22 112.49 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.28 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.627 2.218 . . . . 74.32 112.382 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.58 144.98 43.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 55.14 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.18 150.6 26.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.868 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.81 158.54 36.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.621 0.724 . . . . 73.41 111.152 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -29.04 24.86 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.685 2.257 . . . . 70.32 112.388 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.862 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.468 0.482 . . . . 54.23 112.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -164.83 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.698 2.265 . . . . 72.14 112.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.34 149.88 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 61.31 110.88 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -141.09 139.77 19.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.63 0.728 . . . . 71.21 110.862 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 79.92 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.708 2.272 . . . . 72.12 112.321 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.0 mtm -150.96 178.73 8.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 70.13 110.891 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.93 -172.05 54.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 33.45 112.458 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -32.39 18.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 74.24 112.346 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.5 -43.79 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.926 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 21.22 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 81.38 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.622 2.214 . . . . 72.33 112.338 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -115.61 145.21 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.955 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.52 150.68 26.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 53.34 110.846 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.94 158.58 36.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 73.03 111.073 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -29.13 24.84 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.734 2.289 . . . . 71.14 112.358 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.831 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.418 0.454 . . . . 74.32 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.88 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.656 2.238 . . . . 73.04 112.359 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.22 149.67 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.928 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -140.86 139.79 20.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.691 0.758 . . . . 54.02 110.924 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 79.97 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.249 . . . . 72.21 112.37 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.7 mmt -150.93 178.76 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 72.55 110.872 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.6 -172.05 54.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 51.24 112.493 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -32.66 18.53 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.759 2.306 . . . . 54.35 112.312 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -91.13 -43.86 9.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.11 110.882 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.96 -93.98 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.698 -0.763 . . . . 70.44 112.496 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 81.19 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 74.53 112.387 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.28 145.08 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 62.24 110.93 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.34 150.58 26.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.04 110.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.8 158.51 36.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.551 0.691 . . . . 64.15 111.176 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -29.07 25.0 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.709 2.273 . . . . 52.44 112.392 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.855 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.381 0.434 . . . . 44.13 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 64.33 112.353 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.32 150.17 24.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 64.21 110.898 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.5 139.89 19.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.631 0.729 . . . . 71.22 110.882 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 79.69 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.27 . . . . 62.53 112.3 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mtp -150.68 178.86 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.931 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.73 -171.95 54.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.508 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.673 2.248 . . . . 72.04 112.343 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -91.47 -43.85 9.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.99 -93.65 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 73.04 112.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 81.45 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.623 2.216 . . . . 71.2 112.371 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -115.87 145.54 42.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 72.45 110.882 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.79 150.97 26.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.13 110.854 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.11 158.64 36.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.694 0.759 . . . . 71.02 111.097 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.2 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 64.21 112.392 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 62.41 110.883 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.447 0.47 . . . . 62.3 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -164.81 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.633 2.222 . . . . 72.11 112.342 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.31 149.71 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 55.3 110.887 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -141.05 139.77 19.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.25 110.933 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 79.62 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 64.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.1 mmt -150.61 178.79 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 74.11 110.867 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -172.02 54.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 54.02 112.52 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 -32.55 18.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.666 2.244 . . . . 73.4 112.314 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -91.26 -43.81 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.954 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.81 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 25.13 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 81.38 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.711 2.274 . . . . 72.14 112.329 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -115.82 145.19 43.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 65.0 110.83 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.45 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.13 110.872 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.95 158.64 36.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 42.43 111.097 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -29.15 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 72.15 112.341 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.835 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 121.462 0.479 . . . . 51.32 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -164.86 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.694 2.263 . . . . 63.41 112.354 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.25 149.86 24.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.13 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -141.08 139.79 19.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.618 0.723 . . . . 72.2 110.88 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 80.15 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.678 2.252 . . . . 74.5 112.309 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm -151.14 178.64 9.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.55 110.847 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -172.04 54.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 73.13 112.44 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.4 18.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 64.33 112.353 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -91.38 -43.82 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 72.21 110.912 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.85 0.63 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.665 -0.779 . . . . 62.25 112.46 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 81.31 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.674 2.249 . . . . 53.01 112.414 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -115.52 144.95 43.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.948 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.8 m -107.22 150.51 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.825 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.75 158.61 36.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.653 0.739 . . . . 72.34 111.112 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.96 24.57 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.627 2.218 . . . . 71.42 112.348 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.867 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 121.372 0.429 . . . . 50.25 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -164.73 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.657 2.238 . . . . 74.55 112.329 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.7 150.55 23.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 53.03 110.88 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.05 140.01 18.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.629 0.728 . . . . 75.33 110.888 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 78.95 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.268 . . . . 75.43 112.33 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.4 mmt -149.58 179.04 8.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.95 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.42 -171.96 54.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.793 -0.718 . . . . 43.13 112.562 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.59 18.03 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.702 2.268 . . . . 75.43 112.346 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -90.98 -43.88 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.909 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 73.3 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 81.42 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.631 2.221 . . . . 64.12 112.346 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -115.99 146.31 42.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.23 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -108.45 151.16 26.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.05 110.858 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 pt -112.51 158.77 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.671 0.748 . . . . 60.42 111.089 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -29.34 23.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 73.24 112.364 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.41 110.877 179.88 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 CA-C-O 121.415 0.453 . . . . 44.44 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -163.52 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.676 2.251 . . . . 64.14 112.37 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.13 150.58 22.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -140.43 138.26 18.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.667 0.746 . . . . 72.4 110.811 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.63 0.88 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.693 2.262 . . . . 75.41 112.336 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.1 mtp -152.61 179.35 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.01 110.836 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.55 -171.87 54.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 72.45 112.438 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -32.72 18.51 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 72.22 112.35 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -91.19 -43.86 9.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 -94.42 0.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 62.13 112.54 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 80.62 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.7 2.267 . . . . 73.52 112.377 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.31 143.29 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 74.34 110.918 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.5 30.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 54.51 110.915 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.94 157.74 36.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.699 . . . . 61.01 111.167 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -28.33 25.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 71.32 112.314 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.814 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.438 0.466 . . . . 62.34 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -163.46 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.627 2.218 . . . . 74.54 112.354 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.3 m -101.23 150.41 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.918 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -140.17 138.23 19.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 64.43 110.927 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.695 2.263 . . . . 40.02 112.309 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.9 mtp -152.58 179.27 8.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 71.43 110.886 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.59 -171.85 54.2 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.67 18.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 70.1 112.316 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -91.18 -43.85 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.309 -0.405 . . . . 73.24 110.916 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.51 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 54.25 112.501 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 80.81 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.601 2.201 . . . . 62.43 112.399 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.35 143.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.787 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -106.78 146.53 30.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 50.23 110.851 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -109.01 157.82 35.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 72.41 111.106 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -28.48 25.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.65 2.233 . . . . 53.41 112.38 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.887 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 121.409 0.45 . . . . 64.14 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.5 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.728 2.285 . . . . 74.04 112.355 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.21 150.09 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.853 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -139.84 138.03 19.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.677 0.751 . . . . 74.52 110.908 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 80.66 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.69 2.26 . . . . 52.42 112.308 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.2 mtt -152.67 179.43 8.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.859 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.53 -171.8 54.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.773 -0.727 . . . . 73.24 112.492 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -32.52 18.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.651 2.234 . . . . 54.54 112.347 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.36 -43.83 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 65.34 110.91 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.76 -94.32 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.826 -0.702 . . . . 65.44 112.521 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 80.61 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.679 2.253 . . . . 73.22 112.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.18 143.02 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 63.44 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -106.8 146.23 31.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.844 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.67 157.72 35.94 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.563 0.697 . . . . 74.41 111.192 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -28.24 25.65 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 64.42 112.378 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.925 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.448 0.471 . . . . 21.01 112.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -163.43 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.678 2.252 . . . . 74.54 112.4 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.28 150.62 22.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 71.11 110.824 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -140.4 138.28 18.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.713 0.768 . . . . 74.43 110.836 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.68 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 54.11 112.304 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.3 mtp -152.65 179.34 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 64.0 110.853 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.61 -171.77 54.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.753 . . . . 34.42 112.516 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 -32.57 17.8 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.41 112.307 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.24 -43.88 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.896 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.86 -94.4 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 64.52 112.458 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.62 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.668 2.245 . . . . 71.42 112.342 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -113.19 143.29 44.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 71.24 110.938 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -107.02 146.56 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 72.52 110.897 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.93 157.86 35.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.719 . . . . 73.52 111.116 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -28.52 24.94 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.728 2.285 . . . . 65.44 112.291 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.895 179.934 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 121.474 0.486 . . . . 21.23 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 75.22 112.352 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.39 150.41 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.01 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -140.3 138.16 18.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.689 0.757 . . . . 71.23 110.887 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 79.89 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 70.33 112.343 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.9 mmm -151.5 179.52 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.36 -171.82 54.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 42.21 112.489 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -32.69 17.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 54.5 112.292 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -90.94 -43.93 9.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.879 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.66 -94.47 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.693 -0.765 . . . . 60.24 112.552 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 80.83 0.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.72 2.28 . . . . 74.35 112.294 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.59 143.31 44.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 63.01 110.952 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -107.0 146.68 30.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.832 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.11 157.89 35.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.634 0.73 . . . . 75.42 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -28.59 24.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.219 . . . . 62.4 112.371 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.849 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 121.431 0.462 . . . . 70.23 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.601 2.201 . . . . 73.25 112.331 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.27 149.88 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.927 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.75 138.08 19.44 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 75.12 110.887 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 79.88 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.281 . . . . 63.32 112.372 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 mmt -151.54 179.46 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.905 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.5 -171.87 54.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 74.23 112.504 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.67 18.17 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.607 2.205 . . . . 63.42 112.319 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -91.04 -43.85 9.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 73.44 110.978 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 51.41 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 81.0 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.612 2.208 . . . . 75.45 112.297 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.72 143.21 45.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 65.54 110.819 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.66 30.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 61.01 110.85 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.12 157.77 36.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 61.3 111.137 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -28.45 25.63 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.655 2.237 . . . . 70.52 112.415 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 71.11 110.803 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.463 0.479 . . . . 62.41 112.43 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -163.5 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.679 2.253 . . . . 70.52 112.365 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.44 149.63 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.04 110.828 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.42 137.76 19.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.589 0.709 . . . . 73.42 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 78.62 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 65.31 112.379 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -149.98 179.88 7.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.45 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.24 -172.01 54.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.681 -0.771 . . . . 62.42 112.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -32.81 17.46 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.287 . . . . 73.23 112.333 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -90.62 -43.86 9.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.41 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -94.71 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 64.43 112.516 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 80.63 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.674 2.25 . . . . 71.51 112.381 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.42 143.67 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.43 110.861 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.7 m -107.36 146.77 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 52.41 110.891 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.22 157.77 36.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 71.15 111.074 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -28.62 25.22 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.657 2.238 . . . . 71.15 112.354 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.931 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 121.431 0.462 . . . . 54.2 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.63 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.674 2.249 . . . . 72.14 112.355 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.0 m -100.36 146.52 26.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.833 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -140.64 140.32 22.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.703 0.763 . . . . 72.31 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 77.55 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 52.21 112.269 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 31.1 mtt -143.54 -179.94 6.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.96 53.51 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.762 -0.732 . . . . 34.02 112.505 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -41.98 3.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 74.51 112.374 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -78.7 -43.97 24.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.3 110.899 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.02 -98.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 72.33 112.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 83.68 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.68 2.253 . . . . 73.32 112.371 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -118.62 144.69 45.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.944 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 10.0 m -101.67 145.36 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 64.24 110.846 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 pt -108.92 158.39 34.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.625 0.726 . . . . 64.54 111.147 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 -28.44 24.7 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 73.22 112.35 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 62.3 110.86 179.839 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 121.41 0.45 . . . . 73.42 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -163.57 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.247 . . . . 74.44 112.376 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.8 m -101.08 152.02 21.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 54.41 110.862 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.84 137.88 19.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.681 0.753 . . . . 74.05 110.866 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 78.18 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.714 2.276 . . . . 74.31 112.353 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 17.1 mtp -155.07 -178.98 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.933 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.88 -173.62 43.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 55.21 112.495 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.61 -17.91 37.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 73.12 112.464 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 -42.6 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 74.44 110.925 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.42 -87.91 0.43 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.716 -0.754 . . . . 72.15 112.493 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 86.28 0.58 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.752 2.302 . . . . 52.4 112.354 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -123.04 143.5 49.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.43 . . . . 64.34 110.824 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -111.19 146.72 36.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.35 110.929 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.65 157.28 36.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.598 0.713 . . . . 73.12 111.081 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -27.88 26.13 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.669 2.246 . . . . 71.24 112.371 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.877 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.414 0.452 . . . . 23.33 112.521 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -165.21 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.694 2.263 . . . . 72.41 112.328 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 1.8 m -104.3 155.81 18.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 73.2 110.899 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -145.05 139.86 15.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 62.23 110.834 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 78.53 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 62.22 112.285 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.58 179.69 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.11 110.835 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.58 -171.68 54.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 65.11 112.469 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -32.66 17.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 70.42 112.318 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -91.13 -43.96 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.41 110.902 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 75.1 112.457 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 81.17 0.82 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.729 2.286 . . . . 71.12 112.377 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HE1' HG23 ' A' ' 14' ' ' ILE . 14.1 p90 -115.18 148.51 38.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 70.15 110.936 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.4 m -110.38 151.45 27.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 73.4 110.871 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HE1' ' A' ' 12' ' ' PHE . 2.4 pt -114.07 159.57 35.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.665 0.745 . . . . 64.2 111.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 107.93 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.693 2.262 . . . . 75.32 112.326 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.43 110.917 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.43 0.461 . . . . 64.01 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -164.82 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.681 2.254 . . . . 62.44 112.379 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.29 149.79 24.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 53.1 110.896 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -140.99 139.84 20.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.628 0.728 . . . . 55.04 110.861 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 80.08 0.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.686 2.258 . . . . 74.54 112.392 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.3 mtm -151.14 178.69 8.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.891 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.79 -172.02 54.16 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 63.12 112.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.42 18.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.74 2.293 . . . . 74.35 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -91.43 -43.85 9.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.79 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.773 -0.727 . . . . 72.44 112.509 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 81.37 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.653 2.235 . . . . 74.11 112.391 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 144.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.86 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.13 150.5 26.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.21 110.921 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.71 158.65 35.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 73.52 111.134 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -28.99 24.16 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.681 2.254 . . . . 72.44 112.339 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 64.3 110.929 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.406 0.448 . . . . 54.2 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.709 2.272 . . . . 75.22 112.324 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.16 149.93 24.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 64.32 110.849 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -141.14 139.74 19.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 75.11 110.837 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 80.22 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.725 2.283 . . . . 63.45 112.385 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 mtp -151.39 178.73 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 73.14 110.878 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.57 -171.97 54.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 53.31 112.516 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -32.62 18.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.692 2.261 . . . . 74.33 112.266 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -91.17 -43.79 9.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.965 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.87 -93.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 75.42 112.515 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 81.04 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.7 2.267 . . . . 64.11 112.303 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.11 145.0 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.04 110.869 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.26 150.38 26.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 62.25 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.64 158.59 36.03 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.579 0.704 . . . . 71.53 111.193 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -29.05 24.6 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.239 . . . . 73.32 112.37 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.868 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 121.417 0.454 . . . . 65.14 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.69 2.26 . . . . 62.43 112.343 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.37 149.63 24.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 72.03 110.855 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -140.99 139.8 20.12 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 73.32 110.836 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 79.58 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.41 112.306 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -150.5 178.88 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 61.21 110.878 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -171.97 54.23 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 50.41 112.469 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.54 18.41 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 55.31 112.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -91.16 -43.89 9.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 75.24 110.916 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.9 -93.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 71.4 112.506 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 81.35 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.656 2.237 . . . . 61.25 112.368 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 145.12 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.849 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.34 150.8 26.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.99 158.65 36.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.03 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -29.07 24.1 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.675 2.25 . . . . 73.14 112.295 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.5 110.895 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 121.43 0.461 . . . . 50.14 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -164.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 63.23 112.297 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.17 149.75 24.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.924 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.0 139.87 20.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.726 . . . . 73.21 110.894 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 79.98 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 72.34 112.323 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.1 mmt -150.97 178.7 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.88 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.8 -172.03 54.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 74.4 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.724 2.282 . . . . 74.13 112.355 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -91.32 -43.92 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.97 -93.85 0.63 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 63.22 112.49 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.28 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.627 2.218 . . . . 74.32 112.382 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.58 144.98 43.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 55.14 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.18 150.6 26.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.868 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.81 158.54 36.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.621 0.724 . . . . 73.41 111.152 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -29.04 24.86 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.685 2.257 . . . . 70.32 112.388 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.862 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.468 0.482 . . . . 54.23 112.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -164.83 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.698 2.265 . . . . 72.14 112.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.34 149.88 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 61.31 110.88 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -141.09 139.77 19.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.63 0.728 . . . . 71.21 110.862 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 79.92 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.708 2.272 . . . . 72.12 112.321 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.0 mtm -150.96 178.73 8.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 70.13 110.891 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.93 -172.05 54.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 33.45 112.458 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -32.39 18.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 74.24 112.346 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.5 -43.79 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.926 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 21.22 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 81.38 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.622 2.214 . . . . 72.33 112.338 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -115.61 145.21 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.955 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.52 150.68 26.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 53.34 110.846 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.94 158.58 36.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 73.03 111.073 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -29.13 24.84 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.734 2.289 . . . . 71.14 112.358 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.831 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.418 0.454 . . . . 74.32 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.88 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.656 2.238 . . . . 73.04 112.359 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.22 149.67 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.928 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -140.86 139.79 20.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.691 0.758 . . . . 54.02 110.924 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 79.97 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.249 . . . . 72.21 112.37 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.7 mmt -150.93 178.76 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 72.55 110.872 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.6 -172.05 54.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 51.24 112.493 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -32.66 18.53 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.759 2.306 . . . . 54.35 112.312 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -91.13 -43.86 9.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.11 110.882 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.96 -93.98 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.698 -0.763 . . . . 70.44 112.496 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 81.19 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 74.53 112.387 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.28 145.08 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 62.24 110.93 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.34 150.58 26.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.04 110.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.8 158.51 36.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.551 0.691 . . . . 64.15 111.176 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -29.07 25.0 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.709 2.273 . . . . 52.44 112.392 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.855 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.381 0.434 . . . . 44.13 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 64.33 112.353 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.32 150.17 24.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 64.21 110.898 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.5 139.89 19.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.631 0.729 . . . . 71.22 110.882 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 79.69 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.27 . . . . 62.53 112.3 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mtp -150.68 178.86 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.931 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.73 -171.95 54.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.508 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.673 2.248 . . . . 72.04 112.343 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -91.47 -43.85 9.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.99 -93.65 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 73.04 112.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 81.45 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.623 2.216 . . . . 71.2 112.371 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -115.87 145.54 42.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 72.45 110.882 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.79 150.97 26.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.13 110.854 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.11 158.64 36.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.694 0.759 . . . . 71.02 111.097 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.2 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 64.21 112.392 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 62.41 110.883 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.447 0.47 . . . . 62.3 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -164.81 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.633 2.222 . . . . 72.11 112.342 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.31 149.71 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 55.3 110.887 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -141.05 139.77 19.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.25 110.933 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 79.62 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 64.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.1 mmt -150.61 178.79 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 74.11 110.867 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -172.02 54.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 54.02 112.52 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 -32.55 18.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.666 2.244 . . . . 73.4 112.314 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -91.26 -43.81 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.954 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.81 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 25.13 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 81.38 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.711 2.274 . . . . 72.14 112.329 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -115.82 145.19 43.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 65.0 110.83 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.45 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.13 110.872 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.95 158.64 36.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 42.43 111.097 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -29.15 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 72.15 112.341 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.835 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 121.462 0.479 . . . . 51.32 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -164.86 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.694 2.263 . . . . 63.41 112.354 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.25 149.86 24.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.13 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -141.08 139.79 19.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.618 0.723 . . . . 72.2 110.88 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 80.15 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.678 2.252 . . . . 74.5 112.309 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm -151.14 178.64 9.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.55 110.847 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -172.04 54.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 73.13 112.44 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.4 18.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 64.33 112.353 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -91.38 -43.82 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 72.21 110.912 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.85 0.63 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.665 -0.779 . . . . 62.25 112.46 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 81.31 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.674 2.249 . . . . 53.01 112.414 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -115.52 144.95 43.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.948 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.8 m -107.22 150.51 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.825 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.75 158.61 36.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.653 0.739 . . . . 72.34 111.112 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.96 24.57 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.627 2.218 . . . . 71.42 112.348 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.867 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 121.372 0.429 . . . . 50.25 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -164.73 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.657 2.238 . . . . 74.55 112.329 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.7 150.55 23.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 53.03 110.88 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.05 140.01 18.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.629 0.728 . . . . 75.33 110.888 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 78.95 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.268 . . . . 75.43 112.33 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.4 mmt -149.58 179.04 8.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.95 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.42 -171.96 54.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.793 -0.718 . . . . 43.13 112.562 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.59 18.03 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.702 2.268 . . . . 75.43 112.346 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -90.98 -43.88 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.909 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 73.3 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 81.42 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.631 2.221 . . . . 64.12 112.346 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -115.99 146.31 42.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.23 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -108.45 151.16 26.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.05 110.858 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 pt -112.51 158.77 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.671 0.748 . . . . 60.42 111.089 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -29.34 23.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 73.24 112.364 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.41 110.877 179.88 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 CA-C-O 121.415 0.453 . . . . 44.44 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -163.52 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.676 2.251 . . . . 64.14 112.37 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.13 150.58 22.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -140.43 138.26 18.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.667 0.746 . . . . 72.4 110.811 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.63 0.88 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.693 2.262 . . . . 75.41 112.336 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.1 mtp -152.61 179.35 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.01 110.836 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.55 -171.87 54.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 72.45 112.438 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -32.72 18.51 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 72.22 112.35 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -91.19 -43.86 9.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 -94.42 0.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 62.13 112.54 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 80.62 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.7 2.267 . . . . 73.52 112.377 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.31 143.29 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 74.34 110.918 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.5 30.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 54.51 110.915 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.94 157.74 36.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.699 . . . . 61.01 111.167 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -28.33 25.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 71.32 112.314 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.814 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.438 0.466 . . . . 62.34 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -163.46 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.627 2.218 . . . . 74.54 112.354 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.3 m -101.23 150.41 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.918 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -140.17 138.23 19.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 64.43 110.927 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.695 2.263 . . . . 40.02 112.309 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.9 mtp -152.58 179.27 8.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 71.43 110.886 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.59 -171.85 54.2 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.67 18.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 70.1 112.316 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -91.18 -43.85 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.309 -0.405 . . . . 73.24 110.916 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.51 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 54.25 112.501 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 80.81 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.601 2.201 . . . . 62.43 112.399 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.35 143.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.787 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -106.78 146.53 30.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 50.23 110.851 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -109.01 157.82 35.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 72.41 111.106 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -28.48 25.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.65 2.233 . . . . 53.41 112.38 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.887 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 121.409 0.45 . . . . 64.14 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.5 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.728 2.285 . . . . 74.04 112.355 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.21 150.09 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.853 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -139.84 138.03 19.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.677 0.751 . . . . 74.52 110.908 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 80.66 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.69 2.26 . . . . 52.42 112.308 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.2 mtt -152.67 179.43 8.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.859 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.53 -171.8 54.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.773 -0.727 . . . . 73.24 112.492 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -32.52 18.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.651 2.234 . . . . 54.54 112.347 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.36 -43.83 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 65.34 110.91 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.76 -94.32 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.826 -0.702 . . . . 65.44 112.521 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 80.61 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.679 2.253 . . . . 73.22 112.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.18 143.02 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 63.44 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -106.8 146.23 31.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.844 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.67 157.72 35.94 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.563 0.697 . . . . 74.41 111.192 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -28.24 25.65 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 64.42 112.378 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.925 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.448 0.471 . . . . 21.01 112.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -163.43 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.678 2.252 . . . . 74.54 112.4 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.28 150.62 22.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 71.11 110.824 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -140.4 138.28 18.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.713 0.768 . . . . 74.43 110.836 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.68 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 54.11 112.304 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.3 mtp -152.65 179.34 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 64.0 110.853 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.61 -171.77 54.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.753 . . . . 34.42 112.516 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 -32.57 17.8 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.41 112.307 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.24 -43.88 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.896 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.86 -94.4 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 64.52 112.458 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.62 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.668 2.245 . . . . 71.42 112.342 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -113.19 143.29 44.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 71.24 110.938 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -107.02 146.56 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 72.52 110.897 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.93 157.86 35.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.719 . . . . 73.52 111.116 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -28.52 24.94 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.728 2.285 . . . . 65.44 112.291 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.895 179.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 121.474 0.486 . . . . 21.23 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 75.22 112.352 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.39 150.41 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.01 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -140.3 138.16 18.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.689 0.757 . . . . 71.23 110.887 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 79.89 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 70.33 112.343 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.9 mmm -151.5 179.52 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.36 -171.82 54.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 42.21 112.489 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -32.69 17.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 54.5 112.292 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -90.94 -43.93 9.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.879 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.66 -94.47 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.693 -0.765 . . . . 60.24 112.552 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 80.83 0.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.72 2.28 . . . . 74.35 112.294 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.59 143.31 44.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 63.01 110.952 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -107.0 146.68 30.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.832 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.11 157.89 35.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.634 0.73 . . . . 75.42 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -28.59 24.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.219 . . . . 62.4 112.371 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.849 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 121.431 0.462 . . . . 70.23 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.601 2.201 . . . . 73.25 112.331 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.27 149.88 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.927 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.75 138.08 19.44 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 75.12 110.887 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 79.88 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.281 . . . . 63.32 112.372 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 mmt -151.54 179.46 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.905 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.5 -171.87 54.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 74.23 112.504 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.67 18.17 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.607 2.205 . . . . 63.42 112.319 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -91.04 -43.85 9.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 73.44 110.978 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 51.41 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 81.0 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.612 2.208 . . . . 75.45 112.297 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.72 143.21 45.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 65.54 110.819 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.66 30.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 61.01 110.85 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.12 157.77 36.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 61.3 111.137 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -28.45 25.63 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.655 2.237 . . . . 70.52 112.415 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 71.11 110.803 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.463 0.479 . . . . 62.41 112.43 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -163.5 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.679 2.253 . . . . 70.52 112.365 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.44 149.63 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.04 110.828 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.42 137.76 19.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.589 0.709 . . . . 73.42 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 78.62 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 65.31 112.379 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -149.98 179.88 7.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.45 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.24 -172.01 54.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.681 -0.771 . . . . 62.42 112.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -32.81 17.46 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.287 . . . . 73.23 112.333 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -90.62 -43.86 9.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.41 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -94.71 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 64.43 112.516 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 80.63 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.674 2.25 . . . . 71.51 112.381 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.42 143.67 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.43 110.861 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.7 m -107.36 146.77 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 52.41 110.891 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.22 157.77 36.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 71.15 111.074 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -28.62 25.22 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.657 2.238 . . . . 71.15 112.354 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.931 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 121.431 0.462 . . . . 54.2 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.63 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.674 2.249 . . . . 72.14 112.355 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.0 m -100.36 146.52 26.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.833 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -140.64 140.32 22.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.703 0.763 . . . . 72.31 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 77.55 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 52.21 112.269 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 31.1 mtt -143.54 -179.94 6.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.96 53.51 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.762 -0.732 . . . . 34.02 112.505 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -41.98 3.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 74.51 112.374 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -78.7 -43.97 24.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.3 110.899 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.02 -98.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 72.33 112.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 83.68 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.68 2.253 . . . . 73.32 112.371 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -118.62 144.69 45.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.944 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 10.0 m -101.67 145.36 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 64.24 110.846 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 pt -108.92 158.39 34.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.625 0.726 . . . . 64.54 111.147 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 -28.44 24.7 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 73.22 112.35 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 62.3 110.86 179.839 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 121.41 0.45 . . . . 73.42 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -163.57 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.247 . . . . 74.44 112.376 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.8 m -101.08 152.02 21.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 54.41 110.862 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.84 137.88 19.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.681 0.753 . . . . 74.05 110.866 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 78.18 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.714 2.276 . . . . 74.31 112.353 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 17.1 mtp -155.07 -178.98 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.933 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.88 -173.62 43.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 55.21 112.495 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.61 -17.91 37.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 73.12 112.464 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 -42.6 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 74.44 110.925 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.42 -87.91 0.43 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.716 -0.754 . . . . 72.15 112.493 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 86.28 0.58 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.752 2.302 . . . . 52.4 112.354 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -123.04 143.5 49.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.43 . . . . 64.34 110.824 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -111.19 146.72 36.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.35 110.929 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.65 157.28 36.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.598 0.713 . . . . 73.12 111.081 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -27.88 26.13 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.669 2.246 . . . . 71.24 112.371 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.877 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.414 0.452 . . . . 23.33 112.521 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -165.21 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.694 2.263 . . . . 72.41 112.328 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 1.8 m -104.3 155.81 18.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 73.2 110.899 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -145.05 139.86 15.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 62.23 110.834 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 78.53 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 62.22 112.285 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.58 179.69 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.11 110.835 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.58 -171.68 54.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 65.11 112.469 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -32.66 17.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 70.42 112.318 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -91.13 -43.96 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.41 110.902 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 75.1 112.457 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 81.17 0.82 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.729 2.286 . . . . 71.12 112.377 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HE1' HG23 ' A' ' 14' ' ' ILE . 14.1 p90 -115.18 148.51 38.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 70.15 110.936 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.4 m -110.38 151.45 27.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 73.4 110.871 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HE1' ' A' ' 12' ' ' PHE . 2.4 pt -114.07 159.57 35.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.665 0.745 . . . . 64.2 111.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 107.93 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.693 2.262 . . . . 75.32 112.326 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.43 110.917 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.43 0.461 . . . . 64.01 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -164.82 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.681 2.254 . . . . 62.44 112.379 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.29 149.79 24.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 53.1 110.896 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -140.99 139.84 20.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.628 0.728 . . . . 55.04 110.861 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 80.08 0.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.686 2.258 . . . . 74.54 112.392 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.3 mtm -151.14 178.69 8.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.891 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.79 -172.02 54.16 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 63.12 112.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.42 18.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.74 2.293 . . . . 74.35 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -91.43 -43.85 9.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.79 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.773 -0.727 . . . . 72.44 112.509 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 81.37 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.653 2.235 . . . . 74.11 112.391 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 144.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.86 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.13 150.5 26.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.21 110.921 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.71 158.65 35.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 73.52 111.134 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -28.99 24.16 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.681 2.254 . . . . 72.44 112.339 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 64.3 110.929 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.406 0.448 . . . . 54.2 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.709 2.272 . . . . 75.22 112.324 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.16 149.93 24.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 64.32 110.849 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -141.14 139.74 19.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 75.11 110.837 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 80.22 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.725 2.283 . . . . 63.45 112.385 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 mtp -151.39 178.73 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 73.14 110.878 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.57 -171.97 54.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 53.31 112.516 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -32.62 18.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.692 2.261 . . . . 74.33 112.266 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -91.17 -43.79 9.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.965 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.87 -93.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 75.42 112.515 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 81.04 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.7 2.267 . . . . 64.11 112.303 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.11 145.0 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.04 110.869 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.26 150.38 26.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 62.25 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.64 158.59 36.03 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.579 0.704 . . . . 71.53 111.193 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -29.05 24.6 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.239 . . . . 73.32 112.37 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.868 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 121.417 0.454 . . . . 65.14 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.69 2.26 . . . . 62.43 112.343 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.37 149.63 24.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 72.03 110.855 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -140.99 139.8 20.12 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 73.32 110.836 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 79.58 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.41 112.306 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -150.5 178.88 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 61.21 110.878 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -171.97 54.23 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 50.41 112.469 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.54 18.41 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 55.31 112.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -91.16 -43.89 9.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 75.24 110.916 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.9 -93.78 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 71.4 112.506 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 81.35 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.656 2.237 . . . . 61.25 112.368 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.69 145.12 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.849 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.34 150.8 26.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.99 158.65 36.23 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.03 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -29.07 24.1 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.675 2.25 . . . . 73.14 112.295 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.5 110.895 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 121.43 0.461 . . . . 50.14 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -164.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 63.23 112.297 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.17 149.75 24.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.924 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.0 139.87 20.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.726 . . . . 73.21 110.894 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 79.98 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 72.34 112.323 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.1 mmt -150.97 178.7 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.88 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.8 -172.03 54.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 74.4 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.724 2.282 . . . . 74.13 112.355 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -91.32 -43.92 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.97 -93.85 0.63 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 63.22 112.49 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.28 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.627 2.218 . . . . 74.32 112.382 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.58 144.98 43.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 55.14 110.87 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -107.18 150.6 26.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.868 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 pt -111.81 158.54 36.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.621 0.724 . . . . 73.41 111.152 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -29.04 24.86 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.685 2.257 . . . . 70.32 112.388 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.862 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.468 0.482 . . . . 54.23 112.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -164.83 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.698 2.265 . . . . 72.14 112.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.34 149.88 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 61.31 110.88 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -141.09 139.77 19.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.63 0.728 . . . . 71.21 110.862 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 79.92 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.708 2.272 . . . . 72.12 112.321 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.0 mtm -150.96 178.73 8.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 70.13 110.891 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.93 -172.05 54.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 33.45 112.458 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -32.39 18.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 74.24 112.346 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.5 -43.79 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.926 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 21.22 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 81.38 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.622 2.214 . . . . 72.33 112.338 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -115.61 145.21 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.955 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.52 150.68 26.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 53.34 110.846 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.94 158.58 36.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 73.03 111.073 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -29.13 24.84 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.734 2.289 . . . . 71.14 112.358 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.831 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 121.418 0.454 . . . . 74.32 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.88 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.656 2.238 . . . . 73.04 112.359 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.22 149.67 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.928 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -140.86 139.79 20.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.691 0.758 . . . . 54.02 110.924 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 79.97 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.249 . . . . 72.21 112.37 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.7 mmt -150.93 178.76 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 72.55 110.872 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.6 -172.05 54.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 51.24 112.493 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -32.66 18.53 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.759 2.306 . . . . 54.35 112.312 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -91.13 -43.86 9.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.11 110.882 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.96 -93.98 0.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.698 -0.763 . . . . 70.44 112.496 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 81.19 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 74.53 112.387 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -115.28 145.08 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 62.24 110.93 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.34 150.58 26.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.04 110.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.8 158.51 36.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.551 0.691 . . . . 64.15 111.176 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -29.07 25.0 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.709 2.273 . . . . 52.44 112.392 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.855 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 121.381 0.434 . . . . 44.13 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -164.89 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 64.33 112.353 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.32 150.17 24.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 64.21 110.898 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -141.5 139.89 19.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.631 0.729 . . . . 71.22 110.882 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 79.69 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.27 . . . . 62.53 112.3 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mtp -150.68 178.86 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.931 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.73 -171.95 54.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.508 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.673 2.248 . . . . 72.04 112.343 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -91.47 -43.85 9.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.99 -93.65 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 73.04 112.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 81.45 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.623 2.216 . . . . 71.2 112.371 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -115.87 145.54 42.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 72.45 110.882 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.7 m -107.79 150.97 26.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.13 110.854 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.11 158.64 36.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.694 0.759 . . . . 71.02 111.097 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.2 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 64.21 112.392 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 62.41 110.883 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.447 0.47 . . . . 62.3 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -164.81 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.633 2.222 . . . . 72.11 112.342 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.31 149.71 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 55.3 110.887 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -141.05 139.77 19.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.25 110.933 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 79.62 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 64.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.1 mmt -150.61 178.79 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 74.11 110.867 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 -172.02 54.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 54.02 112.52 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 -32.55 18.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.666 2.244 . . . . 73.4 112.314 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -91.26 -43.81 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.954 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.81 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 25.13 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 81.38 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.711 2.274 . . . . 72.14 112.329 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -115.82 145.19 43.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 65.0 110.83 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.6 m -107.45 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.13 110.872 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 pt -111.95 158.64 36.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 42.43 111.097 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -29.15 24.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 72.15 112.341 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.835 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 121.462 0.479 . . . . 51.32 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -164.86 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.694 2.263 . . . . 63.41 112.354 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.25 149.86 24.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.13 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -141.08 139.79 19.97 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.618 0.723 . . . . 72.2 110.88 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 80.15 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.678 2.252 . . . . 74.5 112.309 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm -151.14 178.64 9.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.55 110.847 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -172.04 54.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 73.13 112.44 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.4 18.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 64.33 112.353 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -91.38 -43.82 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 72.21 110.912 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.94 -93.85 0.63 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.665 -0.779 . . . . 62.25 112.46 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 81.31 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.674 2.249 . . . . 53.01 112.414 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -115.52 144.95 43.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.948 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.8 m -107.22 150.51 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.825 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.75 158.61 36.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.653 0.739 . . . . 72.34 111.112 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.96 24.57 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.627 2.218 . . . . 71.42 112.348 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.867 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 121.372 0.429 . . . . 50.25 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -164.73 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.657 2.238 . . . . 74.55 112.329 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.7 m -103.7 150.55 23.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 53.03 110.88 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.05 140.01 18.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.629 0.728 . . . . 75.33 110.888 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 78.95 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.268 . . . . 75.43 112.33 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.4 mmt -149.58 179.04 8.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.95 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.42 -171.96 54.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.793 -0.718 . . . . 43.13 112.562 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.59 18.03 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.702 2.268 . . . . 75.43 112.346 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -90.98 -43.88 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.909 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 73.3 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 81.42 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.631 2.221 . . . . 64.12 112.346 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -115.99 146.31 42.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.23 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 7.5 m -108.45 151.16 26.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.05 110.858 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 pt -112.51 158.77 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.671 0.748 . . . . 60.42 111.089 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -29.34 23.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 73.24 112.364 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.41 110.877 179.88 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 CA-C-O 121.415 0.453 . . . . 44.44 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -163.52 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.676 2.251 . . . . 64.14 112.37 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.13 150.58 22.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -140.43 138.26 18.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.667 0.746 . . . . 72.4 110.811 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.63 0.88 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.693 2.262 . . . . 75.41 112.336 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.1 mtp -152.61 179.35 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.01 110.836 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.55 -171.87 54.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 72.45 112.438 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -32.72 18.51 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 72.22 112.35 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -91.19 -43.86 9.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 -94.42 0.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 62.13 112.54 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 80.62 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.7 2.267 . . . . 73.52 112.377 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.31 143.29 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 74.34 110.918 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.5 30.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 54.51 110.915 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.94 157.74 36.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.699 . . . . 61.01 111.167 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -28.33 25.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 71.32 112.314 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.814 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.438 0.466 . . . . 62.34 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -163.46 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.627 2.218 . . . . 74.54 112.354 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.3 m -101.23 150.41 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.918 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -140.17 138.23 19.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 64.43 110.927 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.695 2.263 . . . . 40.02 112.309 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.9 mtp -152.58 179.27 8.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 71.43 110.886 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.59 -171.85 54.2 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.67 18.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 70.1 112.316 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -91.18 -43.85 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.309 -0.405 . . . . 73.24 110.916 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.51 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 54.25 112.501 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 80.81 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.601 2.201 . . . . 62.43 112.399 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.35 143.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.787 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -106.78 146.53 30.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 50.23 110.851 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -109.01 157.82 35.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 72.41 111.106 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -28.48 25.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.65 2.233 . . . . 53.41 112.38 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.887 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 121.409 0.45 . . . . 64.14 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.5 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.728 2.285 . . . . 74.04 112.355 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.21 150.09 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.853 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -139.84 138.03 19.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.677 0.751 . . . . 74.52 110.908 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 80.66 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.69 2.26 . . . . 52.42 112.308 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.2 mtt -152.67 179.43 8.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.859 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.53 -171.8 54.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.773 -0.727 . . . . 73.24 112.492 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -32.52 18.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.651 2.234 . . . . 54.54 112.347 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.36 -43.83 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 65.34 110.91 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.76 -94.32 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.826 -0.702 . . . . 65.44 112.521 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 80.61 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.679 2.253 . . . . 73.22 112.342 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -113.18 143.02 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 63.44 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -106.8 146.23 31.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.844 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.67 157.72 35.94 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.563 0.697 . . . . 74.41 111.192 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -28.24 25.65 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 64.42 112.378 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.925 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.448 0.471 . . . . 21.01 112.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -163.43 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.678 2.252 . . . . 74.54 112.4 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.28 150.62 22.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 71.11 110.824 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -140.4 138.28 18.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.713 0.768 . . . . 74.43 110.836 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.68 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 54.11 112.304 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.3 mtp -152.65 179.34 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 64.0 110.853 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.61 -171.77 54.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.753 . . . . 34.42 112.516 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 -32.57 17.8 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.41 112.307 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -91.24 -43.88 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.896 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.86 -94.4 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 64.52 112.458 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.62 0.86 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.668 2.245 . . . . 71.42 112.342 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -113.19 143.29 44.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 71.24 110.938 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.0 m -107.02 146.56 30.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 72.52 110.897 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 pt -108.93 157.86 35.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.719 . . . . 73.52 111.116 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -28.52 24.94 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.728 2.285 . . . . 65.44 112.291 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.895 179.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 121.474 0.486 . . . . 21.23 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 75.22 112.352 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.39 150.41 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.01 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -140.3 138.16 18.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.689 0.757 . . . . 71.23 110.887 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 79.89 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 70.33 112.343 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.9 mmm -151.5 179.52 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.36 -171.82 54.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 42.21 112.489 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -32.69 17.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 54.5 112.292 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -90.94 -43.93 9.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.879 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.66 -94.47 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.693 -0.765 . . . . 60.24 112.552 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 80.83 0.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.72 2.28 . . . . 74.35 112.294 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.59 143.31 44.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 63.01 110.952 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -107.0 146.68 30.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.832 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.11 157.89 35.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.634 0.73 . . . . 75.42 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -28.59 24.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.219 . . . . 62.4 112.371 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.849 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 121.431 0.462 . . . . 70.23 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.601 2.201 . . . . 73.25 112.331 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.4 m -101.27 149.88 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.927 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.75 138.08 19.44 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 75.12 110.887 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 79.88 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.281 . . . . 63.32 112.372 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 mmt -151.54 179.46 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.905 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.5 -171.87 54.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 74.23 112.504 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.67 18.17 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.607 2.205 . . . . 63.42 112.319 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -91.04 -43.85 9.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 73.44 110.978 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.77 -94.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 51.41 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 81.0 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.612 2.208 . . . . 75.45 112.297 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -113.72 143.21 45.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 65.54 110.819 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.8 m -106.94 146.66 30.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 61.01 110.85 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.12 157.77 36.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 61.3 111.137 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -28.45 25.63 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.655 2.237 . . . . 70.52 112.415 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 71.11 110.803 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.463 0.479 . . . . 62.41 112.43 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -163.5 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.679 2.253 . . . . 70.52 112.365 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.5 m -101.44 149.63 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.04 110.828 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.42 137.76 19.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.589 0.709 . . . . 73.42 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 78.62 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 65.31 112.379 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mmt -149.98 179.88 7.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.45 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.24 -172.01 54.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.681 -0.771 . . . . 62.42 112.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 -32.81 17.46 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.287 . . . . 73.23 112.333 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -90.62 -43.86 9.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.41 110.865 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -94.71 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 64.43 112.516 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 80.63 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.674 2.25 . . . . 71.51 112.381 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -113.42 143.67 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.43 110.861 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.7 m -107.36 146.77 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 52.41 110.891 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.22 157.77 36.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 71.15 111.074 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -28.62 25.22 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.657 2.238 . . . . 71.15 112.354 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.931 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 121.431 0.462 . . . . 54.2 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -163.63 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.674 2.249 . . . . 72.14 112.355 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.0 m -100.36 146.52 26.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.833 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -140.64 140.32 22.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.703 0.763 . . . . 72.31 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 77.55 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 52.21 112.269 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 31.1 mtt -143.54 -179.94 6.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.96 53.51 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.762 -0.732 . . . . 34.02 112.505 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -41.98 3.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 74.51 112.374 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -78.7 -43.97 24.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.3 110.899 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.02 -98.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 72.33 112.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 83.68 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.68 2.253 . . . . 73.32 112.371 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -118.62 144.69 45.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.944 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 10.0 m -101.67 145.36 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 64.24 110.846 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 pt -108.92 158.39 34.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.625 0.726 . . . . 64.54 111.147 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 -28.44 24.7 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 73.22 112.35 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 62.3 110.86 179.839 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 121.41 0.45 . . . . 73.42 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -163.57 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.247 . . . . 74.44 112.376 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 2.8 m -101.08 152.02 21.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 54.41 110.862 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.84 137.88 19.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.681 0.753 . . . . 74.05 110.866 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 78.18 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.714 2.276 . . . . 74.31 112.353 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 17.1 mtp -155.07 -178.98 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.933 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.88 -173.62 43.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 55.21 112.495 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.61 -17.91 37.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 73.12 112.464 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 -42.6 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 74.44 110.925 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.42 -87.91 0.43 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.716 -0.754 . . . . 72.15 112.493 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 86.28 0.58 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.752 2.302 . . . . 52.4 112.354 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -123.04 143.5 49.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.43 . . . . 64.34 110.824 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 8.9 m -111.19 146.72 36.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.35 110.929 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.65 157.28 36.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.598 0.713 . . . . 73.12 111.081 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -27.88 26.13 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.669 2.246 . . . . 71.24 112.371 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.877 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.414 0.452 . . . . 23.33 112.521 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -165.21 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.694 2.263 . . . . 72.41 112.328 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 13' ' ' CYS . 1.8 m -104.3 155.81 18.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 73.2 110.899 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -145.05 139.86 15.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 62.23 110.834 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 78.53 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 62.22 112.285 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.58 179.69 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.11 110.835 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.58 -171.68 54.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 65.11 112.469 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -32.66 17.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 70.42 112.318 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -91.13 -43.96 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.41 110.902 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.92 -93.84 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 75.1 112.457 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 81.17 0.82 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.729 2.286 . . . . 71.12 112.377 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HE1' HG23 ' A' ' 14' ' ' ILE . 14.1 p90 -115.18 148.51 38.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 70.15 110.936 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 9.4 m -110.38 151.45 27.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 73.4 110.871 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HE1' ' A' ' 12' ' ' PHE . 2.4 pt -114.07 159.57 35.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.665 0.745 . . . . 64.2 111.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 107.93 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.693 2.262 . . . . 75.32 112.326 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.43 110.917 179.961 . . . . . . . . 0 0 . 1 stop_ save_